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ABSTRACT 
Neutrophils play a critical role in host defense against invading pathogens. 
Chemotaxis, the directed migration of cells, allows neutrophil to seek out the sites of 
inflammation and infection. Neutrophil chemotaxis as well as other type of cell migration 
are considered as cycles composed of highly orchestrated steps. Recently the underlying 
signaling mechanisms of neutrophil chemotaxis are better understood with the studies in 
knockout mice and neutrophil-like cell lines: a number of signaling molecules in 
neutrophil chemotaxis have been identified, and a feedback loop-based model of 
“frontness” and “backness” pathways has been proposed to explain the establishment of 
neutrophil polarity and chemotaxis. However, the signaling mechanisms that control actin 
cytoskeleton reorganization and interaction between the cells and the substratum on 
which cells migrate are still not fully understood. 
In my first research project, we have identified a signaling pathway, mediated by 
non-receptor tyrosine kinase Lyn that is essential for localized integrin activation, leading 
edge attachment, and persistent migration during neutrophil chemotaxis. This pathway 
depends upon Gi protein-mediated activation and leading edge recruitment of Lyn. We 
documented the small GTPase Rap1 as a major downstream effector of Lyn to regulate 
neutrophil adhesion during chemotaxis. Depletion of Lyn abolished chemoattractant-
induced Rap1 activation at the cell's leading edge. Furthermore, Lyn controls spatial 
activation of Rap1 by recruiting the CrkL/C3G protein complex to the leading edge. 
Together, these results provide novel mechanistic insights into the poorly understood 
signaling network that controls leading edge adhesion during neutrophil chemotaxis. 
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In my second research project, we have explored the role of mammalian Target of 
Rapamycin complex 2 (mTORC2) in neutrophil chemotaxis. Lines of evidence indicate 
that mTORC2 is essential for the dynamics of actin cytoskeleton: depletion of mTORC2 
impairs the organization of actin cytoskeleton in mammalian cells, and knockout of 
mTORC2 inhibit chemotaxis in D. discoideum through PKB mediated signaling pathway. 
In our studies, we found that mTORC2 is essential for neutrophil chemotaxis. Depletion 
of mTORC2, not mTORC1, abolishes fMLP-induced actin polymerization and 
chemotaxis in dHL-60 cells. Pharmacological inhibition of mTOR kinase activity and 
AKT phosphorylation fails to affect actin polymerization and chemotaxis in both human 
neutrophils and dHL-60 cells. We further demonstrated that mTORC2 is required for 
fMLP-induced Rac activation. After chemoattractant stimulation, mTORC2 translocates 
to and accumulates at the leading edge of chemotactic cells. Taken together, our findings 
indicate that mTORC2 is essential for neutrophil chemotaxis by controlling actin 
polymerization-mediated leading edge protrusion during neutrophil chemotaxis. 
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CHAPTER 1 BACKGROUND 
1.1 Cell migration 
Both prokaryotic and eukaryotic cells are able to move the cell body from one 
place to another place in certain conditions. This phenomenon is called cell migration. 
Why do cells bother to do that? How can cells achieve this body translocation? What are 
the counterparts of the wheels, engine and steering in these tiny entities when they decide 
to do the business trip? These questions have fascinated biologists for many decades. 
With the help from new tools and methodologies in modern biology, we are beginning to 
unravel the details of cell migration at the molecular level.  
The importance of cell migration 
Cell migration plays a pivotal role in normal development and homeostasis of 
multicellular organisms, and the abnormities of cell migration contribute to the 
progression of many diseases (Lauffenburger and Horwitz, 1996; Ridley et al., 2003). 
During the process of early embryonic development, the formation of three germ layers, 
including endoderm, ectoderm and mesoderm, results from the collective migration of 
cells within the blastocyst. Subsequently, cells migrate toward target locations to form 
various tissues and organs. Errors occurring in this process can cause developmental 
defects or even early embryonic failure. In adult organisms, cell migration is crucial for 
homeostasis, such as mounting an effective immune response and wound healing. Many 
diseases, such as vascular disease, chronic inflammatory diseases, and tumor formation 
and metastasis, are related to aberrant cell migration.  The understanding of cell 
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migration mechanisms will help to develop novel therapeutic strategies to treat cell 
migration-related diseases. 
Embryonic Development 
Cell migration is a robust process that occurs throughout the embryonic 
development (Gilbert, 2010). The life of human and other vertebrate animals starts from a 
zygote, a fertilized egg. The zygote, which contains the entire genetic blueprint for the 
life of a new individual, quickly divides and becomes a blastocyst. During the process of 
gastrulation, cells within the blastocyst collectively migrate to form three germ layers- 
endoderm, ectoderm and mesoderm. Cells within each layer further migrate to target 
locations and develop into different tissues and organs. In the developing brain, for 
example, neuronal precursors migrate to distinct layers where they begin to send 
projections (axons and dendrites) to find their synaptic partners. The guidance of axons 
and dendrites shares many similarities with a migrating cell. The precise guidance to their 
final targets is essential for the formation of neuronal networks and development of 
cognitive functions.  
Homeostasis 
Homeostasis, including effective immune response and wound healing, also relies 
on cell migration. During the immune response, immune cells, such as neutrophils and 
macrophages, migrate out from the circulatory system to the infection sites of 
surrounding stromal tissues, where they destroy invading microorganisms. When cuts in 
the body occur, a complex biological process called wound healing is activated to repair 
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the damage. During this process, immune cells are quickly recruited to prevent invading 
foreigners for entering the wound. Fibroblast cells migrate to the cut sites and coordinate 
with other biological activities to repair the wounds (Grinnell, 1994; Martin and 
Leibovich, 2005).  
Pathology 
Increasing number of migration-related proteins has been implicated in the 
process of embryonic and fetal development. Defects in these proteins can cause the 
failure of early embryonic development, resulting in early loss of pregnancy. Defects in 
the migration related proteins which participate in the later stage of embryonic 
development can result in defective embryos with disorganized tissues. Although some 
defects of migration-related proteins do not affect early fetus, they can cause congenital 
abnormalities such as epilepsy, focal neurological deficits and mental retardation. 
Migration-related proteins are also critical for normal homeostasis. Alteration in 
functions of these proteins contributes to many pathologies. During the immune response, 
the continuous recruiting of immune cells can cause chronic inflammation. In asthma, for 
example, the constant recruitment and activation of white blood cells in the airways 
(lungs) of asthmatics causes tissue damage and results in hyper-reactivity of the airways. 
Similarly, in rheumatoid arthritis inflammatory cells are constantly recruited to the joint 
tissue and cause constant destruction, which results in compromised limb function and 
crippling pain. 
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The migratory cycle 
How is cell migration achieved? Cell migration has been considered a cyclic 
process, comprised of a set of orchestrated steps: protrusion, adhesion, contraction and 
de-adhesion, and translocation (Lauffenburger and Horwitz, 1996; Ridley et al., 2003) 
(Figure 1.1). Cell migration is initiated when cells detect external signals (chemotactic 
molecules). Cells, such as neutrophils, respond to the chemotactic signals by polarizing 
actin and extending a protrusion in the side of membrane  encountering the highest 
concentration of signal (Zigmond, 1977). The new protrusion in the front is then attached 
to the substratum which they migrate on, and stabilized by the de novo adhesion 
complexes which are composed of transmembrane receptor integrin. Integrin-mediated 
adhesion complexes are not only providing the anchor sites for the cell moving forward 
but also initiating and transmitting signals into the inside of cells to regulate cell 
migration (Beningo et al., 2001; Burridge and Chrzanowska-Wodnicka, 1996).  When 
cell polarity is established, signals trigger actin-myosin contraction at the rear and side of 
the cell, which provide the essential forces for cell body translocation. The adhesion 
complexes attenuate and break up in the rear of the cell, and the tail retracts back from 
the rear (Huttenlocher et al., 1997; Lawson and Maxfield, 1995; Worthylake et al., 2001). 
A migratory cycle is completed and continuous cycles allow cell to move toward the 
sources of external signals. 
The modes of cell migration 
Based on the cell type and the context in which the cell is migrating, two modes 
of cell migration have been proposed: single-cell migration and monolayer cell migration. 
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For single-cell migration, cells move as single entities, such as immune cells. As seen in 
monolayer cell migration, cells move in groups, including cells and sheet-like layers. The 
monolayer cell migration is often observed during embryogenesis when sheets of cells or 
loosely associated clusters migrate. However, the mode of cell migration can be changed 
according to the environment. Primary melanoma explants, for example, migrate in 
collagen gels as multicellular clusters and switch to a single cell mode of migration when 
β1 integrin function was blocked (Hegerfeldt et al., 2002). The mechanism of single cell 
migration has been intensively studied over the past decades. Many factors, such as 
adhesion strength and the type of substratum, external migratory signals and the 
organization of the cellular cytoskeleton, have been shown to affect its properties. More 
importantly, based on the nature of interaction between cells and underlying substrate, 
mesenchymal migration and amoeboid migration have been proposed for two prototypes 
of cell migration with distinct characters.  
In slow-moving mesenchymal cells such as fibroblasts, myoblasts, single 
endothelial cells or sarcoma cells, the cyclic steps in migration are most apparent. During 
movement, mesenchymal cells often adopt a spindle-shaped fibroblast-like morphology 
(Grinnell, 1994; Tamariz and Grinnell, 2002). This elongated morphology results from 
integrin-mediated focal adhesions and the presence of high traction forces on both cell 
poles (Ballestrem et al., 2001; Tamariz and Grinnell, 2002). In this process, focal 
adhesions play a central role in motility, by providing strong anchors to the ECM, 
allowing the actin-myosin-based contractile system, known as stress fibers, to pull the 
cell body and trailing edge forward (Huttenlocher et al., 1995; Lauffenburger and 
Horwitz, 1996; Small et al., 1996). Concomitant with integrin and actin localization at 
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substrate-binding sites, mesenchymal cells also recruit surface proteases to digest and 
remodel ECM. Focal adhesion formation and turnover occur on the timescale of 10–120 
min, resulting in relatively slow migration velocities (0.1–2μm/min) on ECM substrate 
(Ballestrem et al., 2001).  
In contrast to mesenchymal cells, fast-moving cells like neutrophils use amoeboid 
movement, exhibit highly polarized morphology and much more rapid membrane 
turnover rates, and seem to glide over the substrate (Haston and Shields, 1985; King et 
al., 1980; Zigmond et al., 1981). Amoeboid movement, which mimics features of the 
single-cell behavior of the amoeba Dictyostelium discoideum, is arguably the most 
primitive and in some ways the most effective form of cell migration. Dictyostelium is an 
ellipsoid cell that has fast deformability (within seconds) and translocates via rapidly 
alternating responses of morphological expansion of the leading edge and contraction of 
the trailing edge (Firtel and Meili, 2000). In higher eukaryotes, amoeboid movement is 
often carried out by hematopoietic stem cells, leukocytes and certain tumor cells (Francis 
et al., 2002; Friedl et al., 2001; Wang et al., 2002b). These cells use a fast crawling type 
of movement that is driven by actin assembly and short-lived interactions with the 
substrate. Like Dictyostelium discoideum, leukocytes including neutrophils and T 
lymphocytes are highly deformable and move at high velocities (2–30 μm/min) (Friedl et 
al., 1998; Smith et al., 2005). In contrast to the mesenchymal migration paradigm, large 
focal adhesions seen in mesenchymal cells and stress fibers were not observed in these 
cells, which may help cells crawl more rapidly (Friedl, 2004; King et al., 1980). 
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1.2 Neutrophil chemotaxis 
Neutrophils, also called polymorphonuclear neutrophils (or PMNs), are the most 
abundant type of white blood cells in mammals.  In response to an injury, Neutrophils act 
as the first line of immune defense and are recruited to fight against invading microbes. 
Chemotaxis, the directed cell migration process by which neutrophils move in response 
to chemical gradients, plays critical role in this defense process. A number of chemicals, 
called chemoattractants, are produced at or proximal to sites of infection and 
inflammation and then diffuse into the surrounding tissue. Neutrophils sense these 
chemoattractants and move in the direction where their concentration is greatest, thereby 
locating the source of the attractants and the associated targets. Neutrophils normally 
circulate in the blood stream and, upon activation, adhere to and squeeze through the 
vascular endothelium, crawling to the sites of infection and inflammation. There they 
phagocytose bacteria and release a number of proteases with antimicrobial activity 
(Schiffmann, 1982). 
The experimental models of neutrophil chemotaxis 
Neutrophils, the fastest moving cells in mammals, are an interesting model system 
for studying amoeboid migration. Furthermore, aberrant neutrophil chemotaxis 
contributes to many pathological conditions of immune diseases, including rheumatoid 
arthritis, ischemia-reperfusion syndrome, acute respiratory distress, and systemic 
inflammatory response syndromes. After stimulation by a variety of chemotactic 
attractants, Neutrophils undergo complex sequential events: reorganization of actin 
cytoskeleton, morphological changes, development of polarity and chemotaxis. The 
signaling mechanisms underlying these events start to be unraveled recently with the 
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experimentation in transgenic mice and human neutrophil cell lines. The dissection of 
signaling pathways underlying neutrophil chemotaxis would help to develop novel 
therapeutic strategies to counteract the progression of diseases caused by aberrant 
neutrophil chemotaxis.  
However, neutrophils are terminally differentiated cells and can not be genetically 
manipulated, which pose a major challenge to study the signaling pathways underlying 
chemotaxis. Most studies of signaling pathways in isolated human primary neutreophils 
solely rely on pharmacological treatments. Although pharmacological approaches have 
the advantage of rapid action on the activity of target enzymes, the specificity and 
efficiency of these pharmacological reagents have been always problematic and should 
be validated in the vitro experiments (Davies et al., 2000). Another approach is to use 
cultured cell lines which can be differentiated into neutrophil-like cells. One of these cell 
lines, human promyelocytic leukemia cell (HL-60), has been validated as neutrophil-like 
cell after DMSO differentiation and has been used in many reports (Hauert et al., 2002; 
Servant et al., 2000b; Srinivasan et al., 2003; Wang et al., 2002a; Xu et al., 2003). 
However, this cell line is very difficult to transfect and variation has been observed in 
different studies. The third strategy is to use transgenic mice which lack specific 
signaling components (Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000). In this 
case, the bone marrow neutrophils can be isolated and used for cell signaling studies and 
chemotaxis analysis. However, functional differences of signaling components in 
chemotaxis may exist between human neutrophils and murine neutrophils. 
Until recently a lot of progress has been made to understand the signaling 
pathways controlling neutrophil chemotaxis. The early studies on signal transduction of 
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neutrophil chemotaxis, which almost exclusively relied on experiments with 
pharmacological inhibitors, have proposed a linear model of neutrophil polarity and 
chemotaxis to connect chemoattractant receptor to the cytoskeleton: attractant receptors 
activate Gi, which then triggers actin polymerization at the leading edge via PI3Ps and 
one or more Rho GTPase. Using a culture model system, differentiated HL-60 cells, and 
combining findings in human primary neutrophils and knockout mice, Henry Bourne’s 
lab at UCSF proposed a model of integrated signaling network to explain the 
establishment of neutrophil polarity and chemotaxis. This model is comprised of two 
divergent signaling pathways which act downstream of different Gi proteins: frontness 
pathways and backness pathways (Xu et al., 2003). In the following sections, I will begin 
with the discussion on functions of individual signaling components and then provide the 
current model of integrated signaling pathways in neutrophil chemotaxis. 
The signaling components of neutrophil chemotaxis 
Chemoattractants and receptors 
Neutrophil chemotaxis is induced by the binding of chemoattractants to surface 
receptors. When injury occurs within the body, chemoattractants are released and 
activated neutrophils crawl to the sites of infection or inflammation. Although they have 
the similar function to induce chemotaxis, the structure of chemoattractants shares little 
similarity. Neutrophil chemoattractants vary from lipid molecules to small short peptides 
and polypeptides. Neutrophils have receptors for bacterial peptides to sense the presence 
of bacterial infection. During the process of bacterial protein synthesis, a formyl group is 
added on the nitrogen of an N-terminal methionyl residue, which becomes a signature for 
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bacterial peptides. The tripeptide N- formyl-met-leu-phe (fMLP) is commonly used for 
studies of neutrophil activation and chemotaxis (Marasco et al., 1984). Neutrophil 
chemotaxis can also occur in the condition of inflammation without bacterial infection. 
When inflammation occurs in the body, mitochondria in the cells of damaged tissues, 
which  are evolutionarily of bacterial origin in protein synthesis machinery, also release 
N-formyl peptide sequences (Carp, 1982). Additional chemoattractants, including the 
lipids leukotriene B4 and platelet-activating factor, are also released by tissues and 
recruited immune cells at the inflammatory sites (Baggiolini et al., 1994; Funk, 2001). 
Furthermore, activated complement system releases the polypeptide chemoattractant C5a. 
Although these chemoattractants differ dramatically in structure, their receptors belong to 
the family of G protein coupled seven–transmembrane-domain receptors (Murphy, 1994; 
Murphy, 1996), GPCRs. These receptors include N-formyl peptide receptor, leukotriene 
B4 receptor, C5a receptor, interleukin-8 receptor, and platelet-activating factor receptor, 
all of which mediate the migratory function of neutrophils to the sites of inflammation. In 
addition to chemotaxis, these chemoattractant receptors also initiate other functions of 
neutrophils, including cytokine release, oxidant production by NADPH oxidase complex, 
production of lipid inflammatory mediators and degranulation.  
Neutrophils respond to stimuli by developing polarized morphology. How 
chemoattractant receptors distribute along the membrane in polarized neutrophils is an 
interesting question, the answer to which may shed light on the mechanism of spatial 
organization of other signal molecules in chemotactic neutrophils. Early studies on 
chemoattractant receptors have conflicting results: a few reports indicate that receptors 
accumulate at the F-actin enriched region (leading edge) (McKay et al., 1991; Walter and 
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Marasco, 1987); the majority of the reports demonstrate the receptors predominantly 
localize in the mid-region of the cell body (Model and Omann, 1996; Schmitt and 
Bultmann, 1990; Servant et al., 1999; Sullivan et al., 1984). In live neutrophil-like cells, 
Servant et al. failed to detect the accumulation of C5a in the leading edge of migrating 
cells by using GFP fused C5a receptor, suggesting that chemotaxis can occur in the 
absence of receptor gradient (Servant et al., 1999). Furthermore, uniform distribution of 
chemoattractant receptor (e.g., cAMP receptor) along the membrane was also observed in 
chemotactic D. discoiddeum (Xiao et al., 1997). Other chemoattractant receptors (e.g., 
CCR5) are found to accumulate in the leading edge of neutrophils (Gomez-Mouton et al., 
2004). Taken together, localization of chemoattractant receptors is not the essential 
initiator for the asymmetric accumulation of spatial signals during neutrophil chemotaxis.   
Gi proteins 
The receptors for fMLP, C5a and IL-8 are coupled to pertussis-toxin sensitive Gi 
proteins (Cockcroft, 1992). Chemoattractant stimulation activates Gi proteins by 
releasing βγ subunits from Gα binding (Gerard and Gerard, 1994). Inhibition studies 
demonstrated that neutrophil chemotaxis depends on Gi protein: cells treated with 
pertussis toxin (PTX), which catalyses the ADP-ribosylation of Gαi and thereby uncouple 
Gi from GPCR stimulation, show complete loss of actin polymerization and other 
leading-edge activities (Molski and Sha'afi, 1987; Spangrude et al., 1985). However, 
Gα12/13 may participate in the signaling pathway to the activation of RhoA (Xu et al., 
2003). Chemotaxis does not depend on the Gαi subunit, which instead is required for 
terminating Gβγ activities (Neptune et al., 1999); Gβγ appears to mediate most of the 
known signaling pathways activated by chemoattractants in leukocytes (Rickert et al., 
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2000; Suire et al., 2006; Weiner, 2002). inactivation of Gβγ or inhibition of  their 
downstream effectors impair neutrophil motility in response to chemoattractants; In D. 
discoideum, genetic deletion of the only Gβγ renders cells non-chemotactic, further 
supporting the importance of Gβγ regulating chemotaxis.  The Gβγ downstream effectors 
include: phosphatidylinositol 3-kinases (PI3Ks), guanosine triphosphatases of the Rho 
family (Rho GTPases), protein kinase C isoforms (PKCs), cytosolic tyrosine kinases, 
mitogen-activated protein kinases (MAPKs) and protein phosphatases (Figure 2.2.).  
 Phosphatidylinositol 3-kinase (PI3Ks) 
Activated phosphatidylinositol 3-kinases (PI3Ks) phosphorylate inositol 
phospholipids on the 3’-position of the inositol ring (Toker and Cantley, 1997; 
Vanhaesebroeck and Waterfield, 1999; Wymann and Pirola, 1998). Three classes of 
PI3Ks have been indentified, of which class I isoforms selectively use 
phosphatidylinositol 4,5-bisphosphate (PIP2) as substrate to generate 
phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P3], which is a second messenger in 
signaling pathways that control cell adhesion, cytoskeletal reorganization, cell growth 
and survival. The PI3K class I is thought to be only class playing roles in chemotaxis for 
both neutrophils and Dictyostelium.  PI3Kγ belongs to class I and consists of p110γ 
catalytic subunit and a 101 KDa regulatory protein. In contrast, other class I family 
members including α, β, δ isoforms consist of a 110 kDa catalytic subunit (p110) and a 
regulatory subunit of differing molecular weights.  
In neutrophils, chemoattractants such as fMLP activate PI3Ks and result in the 
production of the signaling lipid PI(3,4,5)P3. PI3Kγ is directly activated in vivo by Gβγ 
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through the binding of Gβγ-sensitive regulatory subunits (Stephens et al., 1994; Stephens 
et al., 1997; Suire et al., 2005). Other class I isoforms exist more abundantly than PI3Kγ 
and are activated by tyrosine kinase Lyn (Ptasznik et al., 1996; Ptasznik et al., 1995). The 
role of each PI3K class I enzyme in production of PI(3,4,5)P3 is controversial (Naccache 
et al., 2000; Ptasznik et al., 1996; Vlahos and Matter, 1992): some reports suggest that  
Lyn kinase-regulated PI3K predominantly controls the production of PIP3 (as much as 
70% ); other reports indicate that majority of PIP3 (90% or more) is produced through 
PI3Kγ. 
PI3K activation by chemoattractant stimulation can be inhibited by fungal toxin 
wortmannin and LY294002. Some studies have shown that PI3K inhibition impairs some 
responses of neutrophils, including degranulation and oxidant production but fails to 
affect phospholipase C activity and calcium release response (Arcaro and Wymann, 
1993; Nijhuis et al., 2002; Vlahos et al., 1995). Inhibition of PI3Ks also attenuates N-
formyl peptide-induced neutrophil polarization and incorporation of F-actin into 
cytoskeletal actin (Niggli and Keller, 1997; Nijhuis et al., 2002; Vlahos et al., 1995). 
However, the total cellular F-actin content increases normally in these inhibition studies. 
The exact roles of PI3Ks in neutrophil chemotaxis are still not fully understood. In some 
reports, PI3K inhibitors inhibit neutrophil chemotaxis, where neutrophil chemotaxis is 
not altered in other studies (Coffer et al., 1998; Niggli and Keller, 1997; Nijhuis et al., 
2002; Thelen et al., 1995). This discrepancy suggests that PI3K-mediated downstream 
pathways are not essential for netrophil chemotaxis, but are required for optimal 
chemotaxis. Furthermore, mouse neutrophils with PI3Kγ deficiency show dramatically 
reduced production of PI(3,4,5)P3, which indicates PI3Kγ is the major isoform for 
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PI(3,4,5)P3 production in mouse neutrophils (Hirsch et al., 2000; Li et al., 2000; Sasaki et 
al., 2000). Interestingly, chemotaxis is significantly but not completely inhibited in these 
neutrophils. In conclusion, studies using PI3Ks inhibitors and PI3Kγ deficiency 
neutrophils indicate that PI3K is not regulating the initiation of actin polymerization but 
may be involved in the optimal organization and orientation of actin cytoskeleton for 
chemotaxis. 
The major functions of PI3Ks are mediated by their product PI(3,4,5)P3, which 
has been implicated in regulating cell adhesion, cytoskeletal reorganization, growth and 
survival (Toker and Cantley, 1997). PI(3,4,5)P3 is a membrane molecule and functions 
by recruiting proteins containing pleckstrin homology (PH) domains to the membrane, 
where these proteins are activated and assemble signaling complexes. In neutrophils, 
around 20 PI(3,4,5)P3-binding proteins have been identified by a tartgeted proteomic 
screen (Krugmann et al., 2002).  Chemoattractants including N-formyl peptides and IL-8 
induce transient activation of AKT/PKB (Roberts et al., 1999; Sasaki et al., 2000; Tilton 
et al., 1997). This activation of AKT/PKB is inhibited by treatment with PI3K inhibitors, 
suggesting that AKT/PKB activation is the downstream event of PI3K signaling pathway. 
Furthermore, neutrophils from PI3Kγ null mice fail to activate AKT/PKB after 
chemoattractant stimulation (Sasaki et al., 2000). Experimentally the PH domain from 
AKT has been fused with GFP (PH-Akt-GFP) and transfected into cells as a marker for 
PI3P localization during migration.  
A body of research work indicates that PI(3,4,5)P3 plays a role in neutrophil 
polarity and chemotaxis.  In neutrophils and HL-60 cells, application of exogenous 
membrane-permeable PI(3,4,5)P3 induces cell polarization, accumulation of F-actin in 
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lamellipodia, and random motility, which are similar to the responses with uniform 
stimulation of chemoattractants (Niggli, 2000; Weiner et al., 2002). Unexpectedly, these 
responses are dependent on PI3K activity by showing sensitivity to PI3K inhibitors. 
These results suggest that a positive feedback loop exists between PI3K activation and 
PI(3,4,5)P3. Transfection studies with PH-Akt-GFP have revealed that PIP3 localizes in 
the lamellipodia of migrating dHL-60 cells (Servant et al., 2000b; Wang et al., 2002a; 
Weiner et al., 2002). In a polarized HL-60 cell, a much deeper gradient of PI(3,4,5)P3, 
compared to the external gradient of chemoattractant to which it responds, suggests that 
an internal mechanism exists to amplify the effect of the chemoattractant gradient.  
Furthermore, exogenously added PI(3,4,5)P3 induces lamellipodia accumulation of 
PI(3,4,5)P3, which is also inhibited by Rho GTPase inhibitors (Weiner et al., 2002). 
Disruption of the actin cytoskeleton markedly impairs the amplification of the internal 
PI(3,4,5)P3 gradient (Wang et al., 2002a). Taken together, all these results imply the 
existence of a positive feedback loop though which PI(3,4,5)P3 regulates PI3K activity 
via Rho GTPase and actin cytoskeleton. Perturbation of this feedback loop causes cells to 
migrate more slowly and wander more than untreated cells. Thus PI(3,4,5)P3 has been 
called the internal cell “compass” that navigates moving cells. The downstream effectors 
of PI3K include the GEFs for small GTP-binding proteins, and the MAPK cascade, 
which have been implicated in the signaling pathway of neutrophil chemotaxis.      
 Rho family small GTP-binding proteins 
The Rho family members have emerged as the key regulators for actin 
cytoskeletal reorganization, actin-myosin contractility and cell adhesion during 
neutrophil chemotaxis. Small GTP-binding proteins act as a molecular switch for many 
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signaling pathways by alternating in GDP bound form (inactive) and GTP bound form 
(active). The exchange of GTP and GDP at the binding site is regulated by guanine 
nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors 
(GDIs). The intrinsic GTPase activity of small GTP-binding proteins can be modulated 
by GTPase-activating proteins (GAPs). In neutrophils, many small GTP-binding proteins 
have been identified, including Ras, Rac1, Rac2, Cdc42 and Rho. Also the regulators for 
small GTP-binding proteins, such as DOCK2, PIX, Vav1/3, Sos, p120-GAP and 
RhoGDI, have been documented in neutrophils (Bokoch et al., 1994; Dusi et al., 1996; 
Stephens et al., 2008; Zheng et al., 1997). Among the indentified small GTP-binding 
proteins, Rac, Cdc42 and Rho have been intensively investigated and implicated in the 
regulation of neutrophil chemotaxis. 
Rac and Cdc42 have been shown to regulate neutrophil actin polymerization. 
Upon N-formyl peptide stimulation, Rac and Cdc42 are translocated to the plasma 
membrane, where both become activated by resident GEFs (Philips et al., 1995; Quinn et 
al., 1993). The activation of Rac and Cdc42 is dependent on Gi-protein activation (Li et 
al., 2000). PI3K inhibitors markedly but not completely inhibit Rac and Cdc42 activation, 
suggesting that both PI3K dependent and independent activation of Rac and Cdc42 exist 
in neutrophils (Benard et al., 1999). PI3K-independent pathway of Rac activation is 
further suggested by the results that normal Rac2 activation was observed in PI3Kγ null 
mouse neutrophils (Li et al., 2000).  
Cdc42 has been investigated for its role in regulating actin polymerization of 
stimulated neutrophils. It has been hypothesized that active Cdc42 regulates actin 
polymerization via the actin-nucleating protein Arp2/3. In this hypothesis, Cdc42 can link 
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the activated receptor to the activation of Wiskott-Aldrich syndrome protein (WASP), 
which in turn stimulates Arp2/3-mediated actin nucleation reaction (Machesky and Insall, 
1998; Machesky et al., 1999).  In vitro experiments with neutrophils lysate, activated 
Cdc42 induce actin nucleation and F-actin polymerization (Zigmond et al., 1997). Two 
mechanisms, creation of free barbed ends and enhancement of actin elongation, have 
been proposed for active Cdc42-induced actin polymerization.  
Two isoforms of Rac, Rac1 and Rac2, have been identified in neutrophils, of 
which Rac2 is more abundant (> 96%) in human neutrophils (Quinn et al., 1993). 
Chemotaxis is significantly inhibited in neutrophils from Rac2-deficient mice (Roberts et 
al., 1999). Furthermore, neutrophils from a patient with a Rac2 dominant-negative 
mutation show dramatically impaired chemotaxis to N-formyl peptide and IL-8 
(Ambruso et al., 2000; Williams et al., 2000). Actin polymerization was dramatically 
inhibited in Rac2-defiecient neutrophils after chemoattractant stimulation (Roberts et al., 
1999). Rac has been suggested to function downstream of active Cdc42 and regulate 
PI(3,4,5)P3 synthesis, by uncapping the barbed end and initiating actin polymerization 
(Glogauer et al., 2000). In addition, another downstream effector p21-activated kinases 
(PAKs) has been implicated in mediating the effects of activated Rac and Cdc42 in 
neutrophil chemotaxis (Knaus and Bokoch, 1998).   
In contrast to the role of Rac and Cdc42 in actin polymerization, Rho is important 
for uropod formation and release from the substratum. Inhibition of Rho by C3 
exoenzyme impairs neutrophil chemotaxis to N-formyl peptide, although the initiation of 
actin polymerization is not altered (Ehrengruber et al., 1995b; Niggli, 1999; Stasia et al., 
1991; Yoshinaga-Ohara et al., 2002). Neutrophils with Rho inhibition normally polarize 
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and extend the protrusion, but the tails are stuck on the substratum and the cell bodies are 
largely elongated. Several downstream effectors have been identified for activated Rho, 
including ROCK and atypical δ PKC. Inhibition of ROCK by Y-27632 caused the similar 
defect in neutrophils as Rho inhibition, suggesting that ROCK is the major mediator of 
activated Rho modulating myosin II for actin-myosin contractility during neutrophil 
chemotaxis (Kawaguchi et al., 2000; Niggli, 1999). Atypical δ PKC, one of the protein 
kinase C family members (PKCs), has also been implicated acting downstream of 
activated Rho. PKCs include three subfamilies, classical, novel, and atypical, which are 
regulated in different fashions. Neutrophils express classical isozymes α, βI, and βII, 
novel isozyme δ, and atypical isozyme, δ(Kent et al., 1996; Laudanna et al., 1998). PKC δ 
has been shown to be activated and translocated to the plasma membrane after N-formyl 
peptide stimulation. Inhibition of this kinase almost abolishes most of neutrophil 
responses induced by N-formyl peptide. Rho appears to be the upstream regulator of δ 
PKC, suggested by the evidence that Rho inhibition by C3 exoenzyme impairs the 
membrane translocation of δ PKC. However, it is interesting to note that Rho inhibition 
does not affect actin polymerization (Ehrengruber et al., 1995a). The relationship 
between Rho and δ PKC in neutrophil chemotaxis needs to be further investigated. 
It is clear that Rac/Cdc42 and Rho regulate neutrophil chemotaxis in different 
ways. Rac and Cdc42 control actin polymerization and lamellipodium formation. Rho 
modulates the actomyosin contractility machinery and uropod release from the 
substratum.  These two divergent pathways are linked by the downstream effector of 
Rac/Cdc42, PAK, which inactivates MLCK and promotes relaxation of myosin II-based 
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contraction. These two pathways have been suggested to oscillate out of phase such that 
the lamellipodium extension is followed by uropod retraction. 
MAPKs 
The small GTP-binding protein, Ras, is activated in neutrophils upon N-formyl 
peptide stimulation by Gi-protein dependent pathways (Knall et al., 1996; Worthen et al., 
1994). The results that Ras can be activated in the presence of inhibitors of tyrosine 
kinases, PI3K, PKC, rule out these molecules as acting upstream of Ras activation. In 
other cell systems, Ras functions as the initiator of the mitogen-activated protein kinase 
(MAPK) cascade, which has been assumed to be the same in neutrophils. Thus, the 
interest in Ras-mediated signaling is focused on the investigation of MAPK signaling 
pathways in neutrophil chemotaxis. Three modules of MAPKs have been characterized, 
including ERK-1/2 module, p38MAPK module, and JNK/SAPK module, which also has 
been demonstrated to exist in neutrophils.  ERK-1/2 module and p38MAPK module have 
been shown to be  the major activated modules of MAPK cascade in neutrophils 
stimulated by N-formyl peptide (Avdi et al., 1996; Thompson et al., 1993; Worthen et al., 
1994). Inhibition of MEK1/2, the ERK-1/2 module, fails to inhibit neutrophil chemotaxis 
to N-formyl peptide and IL-8, suggesting that this pathway is not essential for the 
migratory function of neutrophils (Coffer et al., 1998; Zu et al., 1998). In contrast, 
inhibitors of p38 MAP kinase impair neutrophil chemotaxis to N-formyl peptide but fail 
to inhibit IL-8 response of neutrophils (Knall et al., 1997; Nick et al., 1997; Zu et al., 
1998). One mechanism has been proposed that p38MAP kinase activated by N-formyl 
peptide relieves the Hsp27-mediated inhibition of actin polymerization via MK2, 
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although the details of this pathway need to be further delineated (Landry and Huot, 
1995; Landry and Huot, 1999).   
  Tyrosine kinases 
Neutrophils express Src family kinases, Syk- and FAK-related tyrosine kinase 
PYK2, which can be activated by several cell surface receptors including the 
chemoattractant receptors, receptor tyrosine kinases and integrins (Berton and Lowell, 
1999; Gaudry et al., 1992; Nijhuis et al., 2002). Studies with inhibitors and mouse 
neutrophils lacking Src family kinase or Syk reveal that these kinases are important for 
integrin-dependent events in neutroplils, such as cell spreading and adhesion (Berton and 
Lowell, 1999; Gaudry et al., 1992; Mocsai et al., 2002). However, inhibition or depletion 
of Src or Syk kinases does not affect N-formyl peptide induced neutrophil migration 
through transwell filters, suggesting that Src family is not essential for neutrophil motility 
(Nijhuis et al., 2002). Interestingly, in under-agarose migration assay, inhibitors of these 
kinases attenuate N-formyl peptide-induced migration. Taken together, tyrosine kinases 
may be required for optimal migration by regulating the interaction between neutrophils 
and the underlying substratum (Yasui et al., 1994).  
Serine/threonine protein phosphatase 
Human neutrophils express both phosphatases 1 and 2A. Inhibition studies in 
neutrophils by using calyculin A and okadaic acid suggest that phosphatase 1 and/ or  2A 
are required for shape maintenance, sustained increase of cytoskeletal actin, N-formyl 
peptide induced chemotaxis (Kreienbuhl et al., 1992; Yokota et al., 1993). However, due 
to the other possible targets of these two inhibitors, these experimental results may be due 
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to off-target effects on neutrophil chemotaxis.  More specific approaches, such as 
knockdown in cultured cell lines and conditional knockout mice, are needed for 
investigating the role of these protein phosphatases in neutrophil chemotaxis. 
Integration of the signaling pathways in neutrophil chemotaxis 
The compass mechanism 
When encountering chemoattractants, neutrophils and neutrophil-like dHL-60 
polymerizes actin, and thrust membrane projection toward the source of chemoattractants 
or random directions in the uniform concentration of chemoattractants. During the 
sensing process of extracellular chemoattractants, a signal is transmitted across the 
membrane to the cell inside. Cells respond to the signal by comparing the signal strength 
throughout all the membrane, determine which side of the membrane has the highest 
stimulation of chemoattractants, and thus develop the protrusion on that side.  The 
comparing mechanism in neutrophils as well as other cell systems has been called 
“compass” (Bourne and Weiner, 2002; Rickert et al., 2000). The chemoattractant gradient 
difference across the cell body of neutrophils is only about 2% (Devreotes and Zigmond, 
1988). However the internal gradients of signal molecules, such as PI(3,4,5)P3, are much 
deeper than outside chemoattractants. Therefore, amplification mechanisms of signaling 
molecules must associate with the intracellular compass. Although more than a billion 
years of eukaryotic evolution have conserved most components of the compass, it is only 
recently that the molecular components and underlying mechanisms of the compass are 
beginning to emerge as positive and negative regulatory feedback loop for the 
organization of leading edge and trailing edge in chemotactic neutrophils (Xu et al., 
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2003). A “front” signaling pathway and a “back” signaling pathway have been proposed 
to explain neutrophil polarity and migration (Figure 1.3).           
The frontness signaling pathway: positive feedback loop of PI(3,4,5)P3, Rac and F-actin  
How neutrophils assemle polarity signal cascades after exposure of 
chemoattractants has been a challenging puzzle for many years. The development of 
neutrophil culture models allow researchers to begin to dissect the complex positive 
feedback mechanisms which neutrophils use to establish and reinforce the leading edge 
(hence, the frontness response).  
The first step toward understanding signals involved in the positive feedback loop 
was the demonstration, first in Dictyostelium (Meili et al., 1999; Parent et al., 1998) and 
later in the neutrophil-like cell line, HL-60 (Servant et al., 2000b; Wang et al., 2002a), 
that phosphatidylinositol-3,4,5-tris-phosphate (PI(3,4,5)P3) and other products of 
phosphoinositide-3′-kinases (PI3Ks) accumulate selectively in membranes at the moving 
cell's leading edge. These 3′-phosphoinositol lipids (PI3Ps) play an essential role in 
organizing the neutrophil's leading edge, as indicated by experiments in which 
pharmacologic inhibitors of PI3Ks block attractant-stimulated formation of actin 
polymers and pseudopods (Servant et al., 2000b; Wang et al., 2002a), apparently by 
abrogating activation of small GTPases of the Rho family, including Rac and Cdc42 
(Benard et al., 1999), which promote formation of actin polymers (Benard et al., 1999; 
Ridley, 2001; Tapon and Hall, 1997).  
lines of  evidence have demonstrated that PI(3,4,5)P3 and Rac serve as signals in 
a positive feedback loop that organizes the leading edge of differentiated HL-60 cells 
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(Srinivasan et al., 2003; Wang et al., 2002a; Weiner et al., 2002). While PI(3,4,5)P3 are 
required for activation of Rac, the reverse is also true: inhibiting Rac activation (with 
toxins or a dominant interfering Rac mutant) prevents PI3P accumulation and 
morphological polarity (Servant et al., 2000b; Srinivasan et al., 2003; Wang et al., 
2002a). Moreover, addition of exogenous PI(3,4,5)P3 can trigger the positive feedback 
loop directly, initiating accumulation of endogenous PI(3,4,5)P3 (Weiner et al., 2002), 
morphologic polarity, and motility in the absence of added chemoattractant (Niggli, 
2000; Weiner et al., 2002); these effects are completely blocked by PI3K inhibitors and 
toxins that inhibit activation of Rho GTPases, indicating that they depend on activation of 
both endogenous PI(3,4,5)P3 synthesis and Rac by the exogenous lipid. Finally, Rac 
stimulates PI(3,4,5)P3 accumulation, at least in part, via the actin polymers that are 
generated in response to activated Rac: either attractant or expression of constitutively 
active Rac can trigger persistent PI(3,4,5)P3 accumulation, but both effects are prevented 
when actin polymerization is blocked by latrunculin B, which sequesters actin monomers 
(Srinivasan et al., 2003; Wang et al., 2002a). Taken together, these observations provide 
a mechanistic explanation for the persistence of robust actin, and PI(3,4,5)P3-containing 
lamellipodium during neutrophil chemotaxis. 
A backness signaling pathway: a model for neutrophil self-organizing polarity 
While the frontness pathway provides a mechanistic explanation for the protrusive 
behavior of neutrophils, it cannot account for the actin-myosin contractility at the back of 
the cells. Studies in the Bourne lab (Xu et al., 2003) suggested that in addition to the 
frontness signals, attractant receptors also trigger a backness pathway that contributes to 
polarity. In contrast to the frontness pathway, which is triggered by Gi, the backness 
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signaling pathway is initiated by G12 and G13. Its downstream components include Rho, 
a Rho-dependent protein kinase (ROCK), and activated myosin, which result in 
contraction of actin-myosin complexes parallel to the cell membranes at the trailing edge. 
At each step of the pathway the corresponding constitutively activating mutants induced a 
global backness response: round cells failed to form actin polymers or translocate PH-
AKT-GFP (the PH domain of protein kinase Akt fused to GFP, used as a spatial probe for 
3′-phosphoinositol lipids (Servant et al., 2000b)) in response to fMLP, but instead 
accumulated activated myosin around the entire cell periphery. Conversely, inhibition of 
these steps impaired cell contractility at the back and caused cells to form a strikingly 
long tail. Myosin II-mediated contractility is also required for reducing the sensitivity of 
the back of the cells, because abrogating the backness pathway renders the entire cell 
sensitive to fMLP stimulation (Xu et al., 2003). 
Divergent frontness and backness signals begin to explain fMLP-induced 
neutrophil polarity. The two sets of signals now allow us to specify roles for proteins that 
mediate neutrophil polarity. While these proteins are well characterized in other cells, the 
model makes a novel contribution, by casting actin polymers and actin-myosin 
assemblies in symmetry-breaking roles, similar to those observed in fish keratocytes 
(Verkhovsky et al., 1999). Polarity is self-organizing because mutual opposition between 
these assemblies induces them to separate from each other in the membrane. Mutual 
incompatibility and inhibition between frontness and backness also provide a mechanistic 
explanation for the ability of neutrophils to polarize in uniform concentrations of 
chemoattractant and to perform U-turns rather than simply reverse polarity in response to 
changes in the direction of the attractant gradient. The neutrophil follows its sensitive 
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“nose” because positive feedback loops at the front and Rho/myosin-mediated 
contraction (inhibition) at the back render the pseudopod much more sensitive to PI3P- 
and Rac-activating actions of the attractants (Xu et al., 2003). 
Conclusion 
The signal transduction underlying neutrophil chemotaxis is revealed as a 
complex interrelated network with multiple signaling branches. Neutrophil chemotaxis 
can be induced by many chemoattractants, including N-formyl peptide, IL-8, C5a and 
platelet-activating factor. Although many signaling pathways have been identified in the 
studies with N-formyl peptide stimulation, many of these signaling pathways are also 
activated in response to other chemoattractants. In addition, some of the signaling 
pathways are triggered by integrin ligation or priming factors but fail to induce neutrophil 
chemotaxis.  
Redundancy is observed in many aspects of the signaling pathways underlying 
neutrophil chemotaxis, which also may contribute to the discrepancy of experimental 
results. PI3K activity can be regulated by Gi-protein interaction, tyrosine kinase -
dependent pathway or cross-talk from other signaling pathways; Rac activity is controlled 
by PI3K –dependent and –independent pathways, actin polymerization can be initiated by 
Rac-dependent and Cdc42-dependent pathways. The activation of either pathway in the 
redundant pathways may be dependent on the context of cells and experimental 
conditions. These redundant and complex signaling pathways allow neutrophils to adapt 
to complicated surrounding environment and migrate toward the site of injury. The nature 
of reduntant signaling pathways reflects the evolution of signaling networks that are 
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required to be robust and refract to the perturbation of outside environments. No matter 
which chemoattratctant is presented to them, neutrophils must temporally and spatially 
coordinate protrusive forces, traction forces, and contractile forces for the cell to move.  
The existence of multiple signaling pathways and interconnections among these 
pathways poses challenges to fully understand the signaling mechanism of neutrophil 
chemotaxis. The signaling model of frontness and backness pathways expands our 
understanding on the molecular property of neutrophil polarity and chemotaxis. However, 
most of the molecular details for both pathways are still not resolved. The formation of 
the leading edge is the hallmark of the neutrophil polarity, of which the actin 
polymerization has been thought to be the driving force. The small GTP-binding proteins 
such as Rac and Cdc42 have been postulated as the essential regulators for the process of 
actin polymerization. However, the upstream molecules as well the downstream 
molecules of Rac /Cdc42 activation are still elusive in neutrophil chemotaxis. Also 
similar to other signaling arms there might exist other signaling pathways to regulate the 
actin polymerization and thus front organization.  
Furthermore, as an important feature in the cyclic process of neutrophil 
chemotaxis, the interactions between neutrophils and the underlying substrate during 
chemotaxis have been largly unexplored, although the importance of cell adhesion in 
neutrophil functions has been shown by many researchers. The signaling mechanisms 
regulating the adhesion formation at the leading edge and the adhesion disassembly of the 
trailing edge are very interesting questions for future studies. When neutrophils encounter 
chemoattractants, multiple signaling pathways have been activated, as observed in the 
stimulation with fMLP. Which signaling pathways are dedicated to control the adhesion 
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and de-adhesion? How are these signaling pathways integrated to regulate these two 
seemingly opposite processes? How are the signaling pathways regulating adhesion and 
de-adhesion temporally and spatially integrated to the other pathways regulating actin 
polymerization and myosin contraction? 
  
28 
 
1.3 Figures 
1
2
4
3
Figure 1.1 Migration cycles. Cell migration is an integrated process that requires 
the continuous, coordinated protrusion (2) formation (3) and disassembly of 
adhesions and retraction of the trailing edge (4).
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Figure 1.2 Overview of signaling molecules activated downstream of GPCRs. 
Chemoattractants, such as fMLP, bind to and activate the seven-transmembrane-domain 
receptors on the cell surface, which trigger the dissociation of coupled trimeric Gi protein 
and release the βγ subunits. Subunits βγ directly or indirectly activate numerous 
signaling molecules which play a role in neutrophil chemotaxis
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Figure 1.3 Frontness and backness signals modulate neutrophil polarity and 
sensitivity to attractant. Abbreviations: R, G protein-coupled receptor; Gi and 
G12/13, trimeric G proteins; Rac and Rho, small Rho GTPases; PI3P, 3′ 
phosphoinositides. The more or less symmetrically distributed actin ruffles and 
PI3P accumulation seen at early times (e.g., 30 s) after application of a 
uniform stimulus presumably mask a fine-textured mosaic of interspersed 
backness and frontness signals, some triggering activation of PI3Ks, Rac, and 
actin polymerization, others promoting activation of Rho and myosin. Localized 
mechanochemical incompatibility of the two cytoskeletal responses, combined 
with the ability of each to damp signals that promote the other (dashed inhibitor 
lines), then gradually drive them to separate into distinct domains of the 
membrane. As a result, within 2 min, a morphologically distinct pseudopod, 
which is highly sensitive to attractant, cleanly demarcates itself from relatively 
insensitive membrane, enriched with myosin, at the back and sides (Xu et al 
2003) .
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CHAPTER 2 NON-RECEPTOR TYROSINE KINASE LYN REGULATES 
LEADING EDGE ADHESION IN NEUTROPHIL CHEMOTAXIS 
(Data presented in this chapter are in press at Journal of Cell Science, 2011) 
2.1 Summary 
Establishing new adhesions at the extended leading edges of motile cells is 
essential for stable polarity and persistent motility. Despite recent identification of 
signaling pathways that mediate polarity and chemotaxis in neutrophils, little is known 
about molecular mechanisms governing cell-extracellular matrix (ECM) adhesion in 
these highly polarized and rapidly migrating cells. Here we documented in neutrophils a 
signaling pathway essential for localized integrin activation, leading edge attachment and 
persistent migration during chemotaxis. This pathway depends upon Gi protein-mediated 
activation and leading edge recruitment of Lyn, a non-receptor tyrosine kinase belonging 
to the Src kinase family. We identified the small GTPase Rap1 as a major downstream 
effector of Lyn to regulate neutrophil adhesion during chemotaxis. Depletion of Lyn in 
neutrophil-like HL-60 cells prevented chemoattractant-induced Rap1 activation at the 
cell's leading edge, while ectopic expression of Rap1 largely rescued the defects induced 
by Lyn depletion. Furthermore, Lyn controls spatial activation of Rap1 by recruiting the 
CrkL/C3G protein complex to the leading edge. Together, these results provide novel 
mechanistic insights into the poorly understood signaling network that controls leading 
edge adhesion during chemotaxis of neutrophils, and possibly other amoeboid cells.  
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2.2 Introduction 
Cell migration has been conceptualized as a cycle (Ridley et al., 2003). After a 
stimulus, cells polymerize actin at the front to initiate protrusions in the direction of 
migration. The protrusions are stabilized by adhering to ECM molecules (adhesion). 
Adhesions serve as traction sites as the cell moves forward and are disassembled at the 
rear, allowing it to detach and retract. In general, strategies for single-cell migration can 
be classified into two patterns: amoeboid movement and mesenchymal migration (Friedl, 
2004). Slow-moving mesenchymal cells (e.g., fibroblasts) often adopt a spindle-shaped 
morphology and adhere via large integrin-mediated plaque-like structures called focal 
adhesions. In contrast, fast-moving cells (e.g., neutrophils) use amoeboid movement 
associated with fast deformability and highly polarized morphology, and move much 
more rapidly. Unlike the mesenchymal migration paradigm, large focal adhesions seen in 
slow moving fibroblasts and stress fibers are not detected in these cells (Friedl, 2004), 
suggesting fundamental differences between amoeboid and mesenchymal cell adhesions, 
but integrin-mediated adhesion is necessary for persistent cell migration (Ley et al., 
2007).  
When exposed to chemoattractants, neutrophils polarize and initiate 
polymerization of actin at the leading edge (pseudopod) to provide the protrusive force. 
Primary neutrophils and neutrophil-like cells have complex signaling pathways that 
control formation of their front and back. A frontness pathway consisting of Rac, the lipid 
products of phosphoinositide-3 kinases (PI3Ks) and polymerized actin organizes the 
leading edge of neutrophils, while the backness signals, including Rho, p160-ROCK and 
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myosin II, lead to contraction of actin-myosin complexes at the trailing edge, causing it to 
de-adhere (Srinivasan et al., 2003; Wang et al., 2002a; Xu et al., 2003). 
Despite these advances, little is known about the regulation of cell-ECM substrate 
adhesion during chemotaxis. Frontness and backness responses per se do not entirely 
account for the persistent polarity and motility of neutrophils when they are exposed to 
chemoattractants. Indeed, chemoattractant stimulation of neutrophils in suspension (i.e., 
without cell adhesion to the substrate) only causes transient membrane extensions, in 
sharp contrast to cells stimulated on substrates, which polarize and migrate persistently 
(Srinivasan et al., 2003; Wang et al., 2002a; Xu et al., 2003). In circulating neutrophils 
β2-integrins (CD18) are highly expressed and mediate the interactions of neutrophils with 
the endothelial cells. The importance of β2 integrin-mediated adhesion in neutrophil 
chemotaxis is highlighted by patients with leukocyte adhesion deficiency (LAD), who 
have decreased number of neutrophils accumulated at the sites of infection and 
inflammation (Bunting et al., 2002). These findings imply a critical role of cell-substrate 
adhesion in regulating neutrophil polarity and motility.  
To dissect the molecular program that governs adhesion of the neutrophil’s 
leading edge during chemotaxis, we assessed the role of proteins known to be involved in 
signaling from chemoattractant receptors and integrins. One such protein is the non – 
receptor tyrosine kinase Lyn, which belongs to the Src kinase family. Emerging evidence 
suggests that Lyn plays a role in modulating integrin signaling and cell migration in 
hematopoietic cells (Baruzzi et al., 2008; Maxwell et al., 2004; O'Laughlin-Bunner et al., 
2001). For instance, neutrophils adhesion to fibrinogen leads to Lyn activation and 
redistribution to the cytoskeletal fractions (Yan et al., 1996). Furthermore, Lyn can also 
34 
 
be activated by multiple chemoattractants in human neutrophils and is required for 
phosphatidylinositol 3,4.5-triphosphate formation (Gaudry et al., 1995; Ptasznik et al., 
1996). Interestingly, Lyn deletion in mouse neutrophils led to enhanced integrin-mediated 
cell responses (Pereira and Lowell, 2003), suggesting that Lyn plays a negative role in 
integrin signaling events. Despite these findings, how Lyn is involved in the regulation of 
chemoattractant-stimulated neutrophil migration has not been well defined. Here we 
uncovered a Lyn-dependent mechanism for promoting localized integrin activation and 
establishing adhesion sites at the leading edge to allow neutrophils to move forward in 
the chemoattractant gradient. 
2.3 Materials and methods 
Reagents and plasmids 
Human fibrinogen, human serum albumin (HSA) and fMLP were from Sigma-
Aldrich. Y-27632, LY 294002 and pertussis toxin were from Calbiochem. Alexa fluor 
488 phalloidin, and Alexa fluor 647 phalloidin were from Invitrogen. ON-TARGETplus 
SMARTpool siRNAs, which contain four siRNAs specifically targeting human Lyn, non-
specific siRNAs and siGLO were from Dharmacon. Mouse or rabbit anti-Lyn antibodies, 
Rabbit anti-CRKL and Rabbit anti-C3G were from Santa Cruz Biotechnology. Rabbit 
anti-Src (pY
418
) antibodies were from Invitrogen. Rabbit anti-CD11/18 antibody was 
from Abcam (ab53009). Mouse anti-human CD11/18 antibody (IB4) (Johansson et al., 
1997) was from Ancell Corporation. Monoclonal antibody m24 for the activation epitope 
of human CD11/18 was kindly provided by Dr. Nancy Hogg (London Research Institute, 
London, UK) and purchased from Abcam (ab13219). Rabbit anti-phospho [Ser19] 
myosin light chain antibody, rabbit anti-Akt antibody, and rabbit anti-phospho [Thr308]-
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Akt antibody were from Cell Signaling Technology. Goat anti-GAPDH polyclonal 
antibody was from GenScript. Other reagents if not mentioned specifically were from 
Sigma.  
The DNA sequences for Lyn 53/56 were amplified from dHL-60 genomic DNA 
by PCR and cloned into pcDNA3 with the EGFP gene at the C-terminus. The dominant 
negative mutant of Lyn 56 (K275D) (Corey et al., 1998) and both shRNA-resistant 
mutants of wild-type Lyn56 and Lyn 56 (K275D) were generated by site-directed 
mutagenesis. Mammalian expression vector encoding pEGFP-C3/Rap1A and pcDNA3-
EGFP-RalGDS were provided by Dr. Mark Philips (New York University, School of 
Medicine, New York, NY) (Bivona et al., 2004) and Dr. Philip Stork (The Vollum 
Institute, Portland, OR) (Wang et al., 2006), respectively. Two target sequences of Lyn 
(shRNA1: forward, 
TGTATCAGCGACATGATTAATTCAAGAGATTAATCATGTCGCTGATACTTTTT
TC, reverse, 
TCGAGAAAAAAGTATCAGCGACATGATTAATCTCTTGAATTAATCATGTCGCT
GATACA; shRNA2; forward, 
TGGTGCTAAGTTCCCTATTATTCAAGAGATAATAGGGAACTTAGCACCTTTTT
TC, reverse, 
TCGAGAAAAAAGGTGCTAAGTTCCCTATTATCTCTTGAATAATAGGGAACTT
AGCACCA) were annealed and cloned into pSicoR vectors for Lyn knockdown. For Lyn 
knockdown with PLKO.1 vectors, two shRNA constructs from Sigma were used 
[SHCLNG-NM_002350: shRNA1 (GCCAAACTCAACACCTTAGAA) and shRNA2 
(GGAAGAAGCCAACCTCATGAA)]. Two shRNA constructs targeting human Rap1A 
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and CrkL, respectively, were from Sigma [SHCLNG-NM_002884: shRNA1 
(GCCAGCATTCCAGACTTCAAA) and shRNA2 (GCTCTGACAGTTCAGTTTGTT)] 
and [SHCLNG-NM_005207: shRNA1 (GTGACTAGGGAGACCATTAAC) and 
shRNA2 (TGTACGGACTCTGTATGATTT)] 
Cell culture, transient transfection, lentiviral production and infection 
Cultivation and differentiation of HL-60 cells were described previously (Wang et 
al., 2002a). For transient transfections of dHL-60 cells, the AMAXA nucleofection 
system was used. Differentiated HL-60 cells (2 x 10
7
, on day 5-6 after DMSO addition) 
were spun down and suspended in nucleofector solution V. DNA (5 µg) or siRNA (3 µg) 
was added to the cells, and the cell-DNA mixture was subjected to nucleofection 
(program T-19). Nucleofected cells were transferred to 20 ml of complete medium. 
Subsequent assays were performed 12–48 hours after transfection. 
For lentiviral production, shRNA-containing plasmids were co-transfected with 
three packaging plasmids pPL1, pPL2 and pPL/VSVG (Invitrogen) into actively growing 
HEK293T cells. After 3 days of transfection, supernatant containing the lentiviral 
particles was concentrated by Lenti-X concentrator (Clontech) and added to growing HL-
60 cells in the presence of 10 μg/ml polybrene for 24 hours. Lyn knockdown cells were 
enriched by cell sorter (Cytomation Plus, Dako) (for pSicoR constructs) or selected in the 
presence of 0.5 μg/ml puromycin for 2 weeks (for PLKO.1 constructs). 
Immunofluorescence and live-cell imaging 
For immunofluorescence studies, cells were suspended in  mHBSS buffer (20 mM 
HEPES, pH 7.4, 50 mM sodium chloride, 4 mM potassium chloride, 1 mM magnesium 
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chloride, 10 mM glucose) with 1% HSA, and then plated on fibrinogen-coated cover 
glass (250 μg/ml fibrinogen) (Schymeinsky et al., 2005) for 20 minutes, washed briefly 
and subsequently stimulated with fMLP for various times. Cells were fixed with 3.7% 
paraformaldehyde in CSK buffer (10 mM HEPES, pH 7.4, 138 mM KCl, 3 mM MgCl2, 
2mM EGTA, 150 mM sucrose) for 15 minutes, permeablized and blocked in CSK buffer 
containing 5% donkey serum and 0.1% saponin (Fluka) for 1 hour, incubated with 
primary antibodies O/N at 4°C followed by Alexa fluor 488 or 594 conjugated goat anti-
mouse or anti-rabbit secondary antibody. Primary antibodies were used at dilutions of 
1:100 (Lyn), 1:100 (p-Src), 1:200 (p-MRLC), 1:100 (β2-integrin), 1:200 (CrkL) and 
1:100 (C3G). Secondary antibodies were used at 2 μg/ml. For the detection of F-actin, 
cells were incubated with Alexa fluor 488- conjugated phalloidin for 10 minutes at RT. 
For live-cell imaging, cells were plated on human fibrinogen-coated surface for 
20 minutes, washed briefly, and subsequently stimulated either with a uniform 
concentration of 100 nM fMLP or a point source of 10 µM fMLP from a micropipette 
(internal diameter of 1 µm, pulled from a glass capillary), as described (Servant et al., 
2000a). To analyze the effects of inhibiting de novo cell adhesion on chemotaxis, dHL-60 
cells were plated on fibrinogen-coated surface for 20 minutes and washed briefly. 
Adherent cells were then incubated with different concentrations of IB4 antibody (0.1 
μg/mL or 0.5 μg/mL) or with mouse isotype IgG for 10 minutes prior to stimulation with 
the fMLP-containing micropipette. DIC images, fluorescent images and combined 
DIC/fluorescence images were collected with a Zeiss 40X NA 1.30 Fluar DIC objective 
or 63X NA 1.4 Plan Apochromat DIC objective on a Zeiss Axiovert 200M microscope. 
All images were collected with a cooled charge-coupled device camera (AxioCam MR3, 
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Zeiss) and processed by the Image J program. Kymograph analysis of leading edge 
protrusion was conducted as described previously (Shin et al., 2010a). 
Immunoprecipitation and western blotting 
Cells (5 x 10
6) were suspended in 90 μl of mHBSS buffer and stimulated with 10 
μl of 1 μM fMLP for various times. fMLP stimulation was terminated by the addition of 
400 μl of 1.25 x RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% NP-40, 150 mM NaCl, 1 
mM EDTA) containing 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF and a protease inhibitor 
cocktail (Sigma). After centrifugation at 14,000 x g for 10 minutes, cell lysates were pre-
cleared with protein A beads and thereafter incubated with 2 µg of anti-Lyn polyclonal 
antibody. After 2 h of incubation at 4ºC, protein A beads were added to the cell lysates. 
The resulting immunoprecipitates were washed with ice-cold RIPA buffer and analyzed 
further with SDS-PAGE. 
For western blotting, cells were lysed in RIPA buffer with the aforementioned 
protease inhibitors. Protein concentrations of the lysates were determined by using DC 
Protein Assay Kit (Bio-Rad). Equivalent amounts of protein (20 μg) were resolved on a 
10% disulfide-reduced SDS-PAGE gel, transferred to Trans-Blot Transfer Medium, 
blocked with 5% nonfat milk in TBST for 1 hour at room temperature, and incubated 
with the primary antibody O/N at 4°C followed by a secondary antibody conjugated to 
horseradish peroxidase (HRP; GE Healthcare). The HRP signals were detected by using 
enhanced chemiluminescence (SuperSignal West Pico). The western blot was stripped 
and re-probed with appropriate antibody according to the manual instruction (Restore 
Western Blot, Thermo Scientific).  
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Microfluidic gradient device 
The microfluidic gradient device comprises of a polydimethylsiloxane (PDMS) 
slab embedded with a Y-shaped fluidic channel and glass substrate as its base. The 
microchannels were fabricated using rapid prototyping and soft lithography as described 
previously (Herzmark et al., 2007; Jeon et al., 2000; Lin and Butcher, 2006). Inlets and 
outlets for the fluids and cells were created in PDMS using a steel punch. The surface of 
the PDMS replica and a clean glass coverslip (Fisher Scientific) were treated with air 
plasma for 90 seconds in a plasma cleaner (Model PDC-001, Harrick Scientific) and 
irreversibly bonded together to complete the device assembly. PTFE tubing (0.022"ID x 
0.042"OD, Cole-Parmer) (Cole-Parmer) inserted into the ports were used to deliver fluid 
to the microchannels. Bubbles were purged from the microchannels by first injecting 
ethanol and then rinsing the channels with PBS. The channel region was then coated with 
250 μg/mL fibrinogen for 1 hour at room temperature before use. Cells were washed, 
suspended in mHBSS containing 1% HSA and injected in the microfluidic device. The 
device was left in the incubator (37°C, 5% CO2) for 20 minutes to allow cells to attach to 
the substrate. The floating cells in the channels were then gently washed away with 
mHBSS. 
To generate soluble gradients, fMLP (500 nM) and mHBSS were infused into the 
device from separate inlets. Solutions were driven using a syringe infusion pump (Pump 
22, Harvard Apparatus) at a flow rate of 0.03 ml/h to generate a concentration gradient in 
the channel by diffusion. Phase contrast images were captured using Axiovision software 
on a Zeiss Axiovert 200M microscope. 
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Rac-GTP /RhoA-GTP assay 
To determine Rac-GTP or RhoA-GTP level in dHL-60 lysate, we used an 
absorbance-based (490 nm) Rac G-LISA kit or RhoA G-LISA (Cytoskeleton, Inc). dHL-
60 cells with or without Lyn depletion were centrifuged for 5 minutes at 1,000 rpm at RT, 
suspended in mHBSS (5 × 10
6
 cells in 90 μl per condition), and stimulated or 
unstimulated with 10 μl of 1 μM fMLP. The reaction was stopped by adding 100 μL of 2 
× lysis buffer (provided with the kit) at 4°C. Subsequent steps were performed as 
described in the protocol attached to the kit. 
Cell adhesion assay 
96-well plates were coated with 100 μg/ml fibrinogen at 4°C O/N and blocked 
with 2 mg/ml heat-denatured BSA for 1 hour at 37°C. Plates were washed with PBS once 
before seeding cells into wells. Cells were labeled with calcium AM (5 μM) for 30 
minutes, washed and suspended in mHBSS. 4 x 10
5
 cells (100 μl) were loaded into each 
well. After 30 minutes incubation with buffer or fMLP (100 nM), each well was washed 
4 times with pre-warmed mHBSS. The remaining cells were then lysed with 100 µl PBS 
containing 0.1% Triton-X 100. The fluorescence intensity of each well was taken by 
microplate reader (SpectraMax M2). The percentage of adherent cells was calculated as 
the ratio of remaining fluorescence intensity and input fluorescence intensity.   
Actin polymerization assay 
The procedure for measuring polymerized actin has already been described 
(Weiner et al., 2006). Briefly, cells were starved in serum-free medium for 1 hour at 37°C 
and stimulated in mHBSS in suspension with 100 nM fMLP at RT. After fixation by 
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3.7% paraformaldehyde for 30 minutes at RT, cells were permeabilized with 0.2% Triton 
X-100 and stained with Alexa 647-conjugated phalloidin (1:100) for 30 minutes at 37°C. 
Stained cells were suspended in ice-cold PBS, and fluorescence was determined by flow 
cytometry with a BD Biosciences LSR II System. The mean fluorescence intensity of the 
cell population was determined. 
Rap1-GTP assay 
To determine the level of Rap1-GTP in dHL-60 cells, we used a Rap1-GTP Pull-
Down and Detection kit from Thermo Scientific. For suspension conditions, dHL-60 cells 
were centrifuged (5 minutes,1,000 rpm) at RT, suspended in mHBSS (10 × 10
6
 cells in 
90 μl for one condition), and stimulated or unstimulated with 100 nM fMLP in a total 
volume of 100 μl. The reaction was stopped by the addition of 0.4 ml ice-old 1.25 × lysis 
buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP-40 and 5% 
glycerol). For adhesion conditions, dHL-60 cells were suspended in mHBSS (5 × 10
6
 
cells in 1 ml for one condition) and plated on fibrinogen-coated 6-well plates for 20 
minutes. Cells were stimulated with 100 nM fMLP for 5 minutes or left unstimulated, and 
cells (both adherent and non-adherent) were lysed in 0.5 ml lysis buffer. Subsequent steps 
were performed according to the manufacturer’s instructions. 
Isolation of primary neutrophils 
Primary neutrophils were isolated from venous blood from healthy human donors. 
Blood was collected into heparin-containing Vacutainer tubes (BD Biosciences) and 
neutrophil isolation procedure was performed within 30 minutes of blood collection using 
PMN isolation medium (Matrix). Red blood cell contaminants were removed by Red 
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Blood Cell Lysis buffer (Roche), which produced more than 97% of neutrophil purity. 
Neutrophils were suspended in RPMI 1640 medium supplemented with 10% fetal bovine 
serum at 37°C until the time of experiments conducted within 8 hours after isolation. 
Statistical analysis 
Statistically significant differences between two groups were determined using 
the heteroscedastic two-tailed Student’s t-Test. The difference with p value less the 0.05 
is considered to be significant. 
2.4 Results 
Lyn expression, activation and localization  
To understand how Lyn controls chemotaxis, we determined its expression, 
activity and subcellular localization in neutrophils. Lyn was highly expressed in primary 
human neutrophils and the neutrophil-like differentiated HL-60 cells (dHL-60), but not in 
undifferentiated HL-60 cells or non-hematopoietic HEK293 cells (Figure 2.1A). The 
upper and lower bands represent the Lyn A and Lyn B isoform, respectively, as 
previously reported (Yi et al., 1991). Differentiated HL-60 cells have been used widely 
for studying neutrophil polarity and chemotaxis (Bodin and Welch, 2005; Gomez-
Mouton et al., 2004; Hauert et al., 2002; Nuzzi et al., 2007; Schymeinsky et al., 2006): 
when differentiated, they exhibit neutrophil morphologies, polarize in response to 
attractants, and migrate in gradients of attractant at rates comparable to primary 
neutrophils (Servant et al., 2000a; Wang et al., 2002a; Xu et al., 2003). Unlike primary 
neutrophils, they can be continuously cultured and are genetically tractable (Neel et al., 
2009; Servant et al., 2000a; Srinivasan et al., 2003; Weiner et al., 2006; Xu et al., 2003). 
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In this study, we used fibrinogen as the ECM substrate to recapitulate the physiological 
microenvironment for neutrophil migration. Fibrinogen is a known ligand for β2-integrin 
in neutrophils (Altieri et al., 1990). 
We analyzed the activity of Lyn by immunoprecipitating endogenous Lyn from 
dHL-60 cell lysates, followed by assessment of the level of activated Lyn using an 
antibody specific for phospho-Src proteins. Phosphorylation of tyrosine residues (at 397 
for Lyn) in the activation loop of the kinase domain up-regulates enzyme activity of Src 
kinase family (Hunter, 1987). Exposure of suspended cells (i.e., in the absence of ECM 
attachment) to the bacteria-derived chemoattractant formyl-Met-Leu-Phe (fMLP) induced 
rapid and robust activation of Lyn, reaching a maximum at 30 sec (6.1 ± 2.4 fold over 
resting condition; mean ± s.e.m), as detected by the phospho-specific antibody (Figure 
2.1B). Treatment of cells with pertussis toxin (PTX) completely abolished Lyn activation 
(Figure 2.1C). Covalent modification of the α subunit of Gi by PTX inactivates Gi and 
abrogates all frontness signals (Xu et al., 2003). In contrast, inhibition of PI3K with a 
specific inhibitor LY294002 expectedly prevented fMLP-induced Akt phosphorylation 
but failed to affect Lyn activation (Figure 2.1C and data not shown). Thus, fMLP-
stimulated Lyn activation depends upon Gi but not PI3K. Interestingly, when exposed to 
fMLP, cells plated on the fibrinogen substrate exhibited a relatively small increase in 
phosphorylated Lyn (10-20%), which sustained for over 10 minutes (data not shown). 
The distinct patterns of Lyn activation between suspended and adherent cells suggested 
differential regulation of Lyn activity under these conditions. 
Immunofluorescence of Lyn in non-stimulated adherent dHL-60 cells was 
distributed cortically around the plasma membranes, with some cytoplasmic localization, 
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but was preferentially distributed to the leading edge of 73% of cells (out of 415 
examined) treated with fMLP, co-localizing with F-actin (Figure 2.2A). The 
immunofluorescence was specific for Lyn, as verified by competition experiments with a 
blocking peptide. The asymmetry of Lyn in fMLP-treated cells was not caused by 
increased amounts of membranes at the front, as shown by dual imaging of Lyn and a 
fluorescent membrane dye (DiD) in the same cells. While membranes were uniformly 
located and in some cases slightly enriched at the leading edge, there was a significant 
increase in Lyn, as shown by the merged image. fMLP-induced leading edge recruitment 
of Lyn was also seen in primary neutrophils (Figure 2.2A, lower panel). In addition, 
fMLP also stimulated asymmetric accumulation of phospho-Src (activated Src) proteins, 
in patterns highly reminiscent of total Lyn (Figure 2.2B). Immunofluorescence of 
phospho-Src was mostly attributed to phospho-Lyn protein, because RNAi-mediated Lyn 
depletion (the next section) nearly completely abolished the phospho-Src 
immunofluorescence. Thus, Lyn is activated and translocates to the leading edge in 
response to fMLP.  
Depletion of Lyn impairs neutrophil chemotaxis 
We next assessed the effect of Lyn depletion on dHL-60 chemotaxis (Figure 2.3 
and Figure 2.4). We transiently knocked down the expression of genes of interest in dHL-
60 cells by using the Amaxa Nucleofection System, allowing us to quickly test genes 
involved in the regulation of neutrophil chemotaxis. Transfection of cells with a pool of 
siRNAs targeting human Lyn reduced Lyn protein by ~80% after 48 hours (Figure 
2.3A,B). In addition, we used a lentivirus-based system to stably express small hairpin 
RNAs (shRNAs) that efficiently depleted Lyn in dHL-60 cells, enabling us to conduct 
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large-scale biochemical analyses. When exposed to an external fMLP gradient, delivered 
by a micropipette, cells transfected with non-specific siRNAs formed well-defined 
leading and trailing edges and migrated rapidly and persistently towards the tip of the 
micropipette (Figure 2.3C). In contrast, although Lyn-depleted cells were capable of 
responding to the fMLP gradient and establishing a leading edge in the direction of the 
pipette, they protruded significantly slower than control cells. Kymograph analysis 
showed that the protrusion speeds for control and Lyn-depleted cells were 6.32 ± 0.44 
μm/min and 3.64 ± 0.31 μm/min (mean ± s.e.m.), respectively (Figure 2.3D,E). 
Concomitant to decreased protrusion, the speed for trailing edge retraction was also 
reduced in Lyn-depleted cells [5.03 ± 0.25 μm/min for control vs. 1.61 ± 0.23 μm/min for 
Lyn depletion (mean ± s.e.m.)]. In addition, the bodies of Lyn-depleted cells were unable 
to detach effectively from the substrate and remained largely stationary, resulting in a 
stretched spindle-shaped morphology (Figure 2.3C) and long trailing edges [32.2 ± 1.3 
μm vs. 19.8 ± 1.6 μm for controls (mean ± s.e.m.)]. In keeping with this result, the 
elongation index (the ratio of the length of a polarized cell when fully extended to the 
width of its pseudopod) of Lyn-depleted cells was greater than that of control cells [2.63 
± 0.23 vs. 1.61 ± 0.11, respectively (mean ± s.e.m.)]. At late stage of stimulation (> 6 
minutes), some of the Lyn-depleted cells (~26%) retracted their leading edges (Figure 
2.3C; cells b and d). 
Interestingly, treatment of dHL-60 cells with PP2, a highly specific inhibitor of 
Src kinase family, failed to mimic the phenotypes of Lyn depletion. In the micropipette 
assay, PP2 treatment caused cells to slightly increase the protrusion and migration speeds. 
A similar result was reported: treatment of mouse and human neutrophils with PP2 did 
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not alter neutrophil migration in experiments with the transwell assay (Fumagalli et al., 
2007). The differential effects between Lyn depletion and PP2 treatment may be due to 
potential complex interplay among Src kinase family. Expression of a number of Src 
family kinases was documented in neutrophils (Korade-Mirnics and Corey, 2000; Lowell, 
2004)  
The chemotactic behaviors of Lyn-depleted cells were also examined with a 
microfluidic gradient device, which assesses migration of cell populations in highly 
stable gradients over a long distance (Figure 2.4). Time-lapse video-microscopy could 
track individual cells as they migrated in the microfluidic chamber (Figure 2.4A). In this 
assay, Lyn depletion markedly impaired neutrophil chemotaxis in an fMLP gradient (1.4 
nM/μm). In contrast to untreated cells (Figure 2.4A,B, upper panel; Figure 2.4D), Lyn-
depleted cells protruded slower and exhibited an elongated morphology (Figure 2.4A,B, 
lower panel; Figure 2.4D). These defects were similar to those in the micropipette assay. 
Notably, the chemotactic index [the ratio of migration in the correct direction to the 
actual length of the migration path (Xu et al., 2005)] was similar between control and 
Lyn-depleted cells (0.93 and 0.91, respectively), suggesting that Lyn depletion did not 
impair directionality of the cells (Figure 2.4C).  
The chemotactic defects in Lyn-depleted cells were likely attributed to the lack of 
Lyn kinase activity, Expression of a GFP-tagged dominant negative kinase-dead Lyn 
mutant (LynK275D) in dHL-60 cells led to defects similar to Lyn depletion. Furthermore, 
transfection of wild-type Lyn, but not the kinase-dead mutant, nearly rescued the defects 
of Lyn depletion (protrusion speed: 6.08 ± 0.31 μm/min for control; 5.36 ± 0.21 μm/min 
for Lyn-depleted cells with Lyn-EGFP rescue) (Figure 2.5A,B,C). Together, these results 
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suggest that Lyn kinase activity might be responsible for Lyn-mediated functions in 
neutrophils during chemotaxis.    
Lyn is not required for the frontness signals 
We next assessed the mechanism by which Lyn controls neutrophil chemotaxis. 
Lyn’s asymmetric localization and the effect of Lyn depletion on cell protrusion led us to 
investigate a potential role in leading edge establishment. It was reported previously that 
actin polymers, phospatidylinositol-3,4,5-phosphate (PIP3), and Rac-GTP are key 
components of the “frontness” pathway that controls leading edge establishment during 
neutrophil chemotaxis (Srinivasan et al., 2003; Xu et al., 2003). We therefore assessed 
whether Lyn depletion reduced these signals. We took advantage of a unique feature of 
neutrophils: their ability to polarize when stimulated with chemoattractants, even in 
suspension. When exposed to fMLP, neutrophils in suspension quickly (within 1–2 
minutes) establish a morphological leading edge (Zhelev et al., 2004). The leading edge 
does not persist and retracts after stimulation (Fechheimer and Zigmond, 1983; Sklar et 
al., 1985; Wang et al., 2002a; Ydrenius et al., 1997). Attractant stimulation of suspended 
neutrophils also suffices to accumulation of polymerized actin, PIP3 and Rac-GTP, albeit 
transiently, consistent with the morphological response (Srinivasan et al., 2003; Wang et 
al., 2002a; Xu et al., 2003). This feature of neutrophils enables us to assess the frontness 
response without input introduced by the outside-in signals from cell-ECM adhesion. 
Under these conditions Lyn depletion failed to prevent the accumulation of polymerized 
actin, Rac-GTP and phospho-Akt (activated Akt, readout for PIP3) in neutrophils 
exposed to fMLP stimulation (Figure 2.6A,B,C), suggesting that signaling pathways 
leading to PI3K, Rac and F-actin activation/formation are not altered by Lyn depletion. 
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Lyn is required for localized activation of β2-integrin and leading edge adhesion 
During migration protrusion and adhesion of the leading edge are coupled (Ridley 
et al., 2003). Therefore, the defects of Lyn depletion on neutrophil chemotaxis could be 
due to inability of these cells to attach their protrusive pseudopods, resulting in slower 
protrusion. This notion is supported by the observation that at late stage of fMLP 
stimulation some Lyn-depleted neutrophils detached and retracted their leading edges, 
implying that the cells failed to stably adhere to the ECM substrate at the front. Thus, Lyn 
might regulate leading edge adhesion, leading us to assess whether Lyn controlled β2-
integrin in neutrophils. In control cells, β2-integrin immunofluorescence was mostly 
distributed at the leading edge after fMLP stimulation, with some diffused localization in 
the cell body. The asymmetric distribution of β2-integrin was confirmed quantitatively by 
using the ratio of immunofluorescence intensity of β2-integrin between the leading edge 
and the cell body (2.54 ± 0.31; mean ± s.e.m.) (Figure 2.7A). The use of ratio of mean 
fluorescence intensity discounts variations in the levels of fluorescence among cells and 
is thus more appropriate for assessing relative accumulation of the fluorescent signals. 
Lyn depletion did not change the asymmetry of β2-integrin localization (2.64 ± 0.19) 
(Figure 2.7A). In contrast, although activated β2-integrin, assessed by using antibody 
m24, exhibited a similar leading edge enrichment in control cells (Ratio: 2.52 ± 0.27), 
Lyn depletion markedly impaired this enrichment (1.35 ± 0.03) (Figure 2.7B,C).  
To investigate whether attenuated β2-integrin activity might be responsible for the 
defects of Lyn depletion, we assessed the effect of a β2-integrin function blocking 
antibody (IB4) on neutrophil migration. We plated dHL-60 cells on fibrinogen and then 
treated them with different doses of IB4 for a short term (10 minutes) prior to fMLP 
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stimulation. This procedure selectively prevented fMLP-induced de novo adhesion 
without significantly altering global adhesion of cells to the fibrinogen substrates 
(Materials and Methods). In the presence of non-specific IgG, dHL-60 cells migrated 
towards the source of fMLP and maintained a highly polarized morphology with well-
developed pseudopods (Figure 2.7D, upper panel). In contrast, cells treated with the 
intermediate dose of IB4 (0.1 μg/mL) migrated with slower-protruding leading edges 
[3.12 ± 0.24 μm/min vs. 5.84±0.38 μm/min for IgG-treated cells (mean ± s.e.m.; n=33 
cells for each condition)] and exhibited elongated morphologies (Figure 2.7D, middle 
panel). Furthermore, at a higher dose (0.5 μg/ml), IB4 treatment caused some cells 
(~28%) to only transiently polarize in response to fMLP, with much smaller leading 
edges and a round-up morphology, most likely due to stronger inhibition of leading edge 
adhesion (Figure 2.7D, lower panel). Thus, blocking cell adhesion with intermediate dose 
of IB4 mirrored Lyn depletion (Figure 2.3C).  
It was reported previously that deletion of Lyn causes mouse neutrophils to 
become hyper-adhesive when they are adherent to surfaces coated with ECM proteins 
(Pereira and Lowell, 2003). Similarly, Lyn-depleted dHL-60 cells exhibited increased 
adhesion to fibrinogen in the absence of fMLP (Figure 2.8A). However, in contrast to 
control cells, which markedly elevated adhesion after fMLP stimulation, Lyn-depleted 
cells only showed a moderate increase (Figure 2.8A). There was no difference in β2-
integrin surface expression between control and Lyn-depleted cells (Figure 2.8B), 
consistent with mouse neutrophils (Pereira and Lowell, 2003). To ask whether elevated 
adhesion may be responsible for the chemotactic defects of Lyn-depleted cells, we treated 
cells with Mn
2+, which triggers β2-integrin activation (Altieri, 1991), causing neutrophils 
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to tightly adhere to the fibrinogen substrate and fail to polarize morphologically in 
response to a fMLP gradient (Figure 2.8C). Immunofluorescence studies showed that 
while the level of activated β2-integrin was high after Mn2+ treatment, F-actin was largely 
diffusely distributed (Figure 2.8D).  
Notably, the defects of Lyn depletion are reminiscent of those induced by 
inhibiting the backness signals, which caused neutrophils to form highly stretched long 
tails (Xu et al., 2003). However, we showed that Lyn was not involved in the regulation 
of the backness pathway or myosin II-mediated contractions (Figure 2.9A,B,C). Lyn 
depletion failed to alter RhoA activity or the level of activated myosin II (phosphorylated 
specifically at Ser19, p[19]-MLC; S3E,F,G). In contrast, treatment of cells with the p160-
ROCK inhibitor Y-26732 markedly reduced the level of phospho-myosin II. 
Furthermore, in contrast to Lyn depletion, Y-27632 treatment, which prevented trailing 
edge retraction, did not alter the speed for leading edge protrusion (5.91±0.37 μm/min) 
(Figure 2.3D). This result is consistent with earlier findings (Shin et al., 2010b), again 
demonstrating differential effects between Lyn depletion and inhibition of the backness 
signals. 
Rap1 is a major effector of Lyn in neutrophils during chemotaxis 
The Ras-like small GTPase Rap1 has emerged as a major mediator of inside-out
 
signaling to integrins (Bos, 2005; Caron et al., 2000; Shimonaka et al., 2003). Rap1 
controls chemokine-induced integrin activation and adhesion (Shimonaka et al., 2003), 
leading us to assess whether Rap1 acted as a downstream target of Lyn in neutrophils 
during chemotaxis.  
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We assayed Rap1-GTP (the activated form of Rap1) by using a previously 
described pull-down method (Zwartkruis et al., 1998). Rap1-GTP levels increased 
transiently in suspended dHL-60 cells after exposure to fMLP, reaching a maximum at 30 
sec (>10 fold over unstimulated control; Figure 2.10A). fMLP stimulation also caused 
adherent cells to markedly increase the levels of Rap1-GTP, which sustained after 
stimulation. A similar activation pattern was reported in primary neutrophils (M'Rabet et 
al., 1998). Rap1 activation was also observed in live cells responding to a gradient of 
fMLP, which induced GFP-RalGDS translocation from the cytosol to plasma membranes 
at the ruffling leading edge (Figure 2.10C,D, upper panel). GFP-RalGDS is a fluorescent 
probe for Rap1-GTP (Wang et al., 2006). A quantitative analysis of the fluorescence 
intensity across the cells revealed a steep gradient of GFP signals in untreated control 
cells (78±21% decrease). In contrast, GFP-tagged Rap1 was largely uniformly 
distributed in the cytoplasm in unstimulated cells and remained diffusely distributed after 
fMLP stimulation (Figure 2.11D), suggesting that the asymmetric accumulation was 
specific for activated Rap1. 
Lyn depletion markedly inhibited fMLP-induced activation of Rap1. We found 
that Lyn depletion reduced fMLP-induced Rap1 activation by 63±12% in suspended 
cells (at 30 sec) (Figure 2.10A,B) and 41±9% in adherent cells. Interestingly, in 
adherent cells without fMLP stimulation Lyn depletion increased the level of activated 
Rap1, in keeping with increased cell adhesion and suggesting that Lyn might inhibit Rap1 
activity under this condition . In addition, Lyn-depleted cells exhibited poor leading edge 
recruitment of GFP-RalGDS, as reflected by much more diffused localization and smaller 
GFP gradients across the cell (36±15 % decrease) (Figure 2.10C,D, lower panel). 
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Moreover, when compared with control cells, the ratio of mean fluorescence intensity of 
GFP-RalGDS between the leading edge and the trailing edge was markedly reduced by 
Lyn depletion (1.40 ± 0.25 for control vs. 1.17 ± 0.11 for Lyn depletion, respectively; 
mean ± s.e.m.), again revealing that asymmetric localization of activated Rap1 was 
impaired. Thus, Lyn is required for chemoattractant-induced activation and asymmetric 
accumulation of Rap1-GTP at the neutrophil's leading edge. 
In addition, Rap1 depletion induced chemotactic defects highly reminiscent of 
those caused by Lyn depletion. Two shRNA constructs effectively reduced the level of 
Rap1A (Figure 2.11A), the predominant isoform of Rap1 in neutrophils (Quilliam et al., 
1991). In accordance to previous reports (Duchniewicz et al., 2006; Li et al., 2007), Rap1 
depletion decreased the number of adherent dHL-60 cells plated on fibrinogen-coated 
substrate. When stimulated with a point source of fMLP, Rap1A-depleted cells protruded 
much slower than cells containing non-targeting shRNA [3.43 ± 0.35 μm/min for Rap1A 
shRNA1 and 2.96 ± 0.13 μm/min for Rap1A shRNA2 vs. 5.85 ± 0.20 μm/min for non-
targeting shRNA (mean ± s.e.m.; n=36 cells for each condition)]. Furthermore, like Lyn-
depleted cells, Rap1A-depleted cells retracted significantly slower (0.83 ± 0.12 μm/min 
vs 4.66 ± 0.45 μm/min for control cells) and developed a spindle-shaped morphology 
(Figure 2.11B,C). The elongation index for Rap1A depleted cells was 2.5±0.32 (mean ± 
s.e.m.; n=23), close to the value of Lyn-depleted cells.  
Together, these results suggested that Rap1 acts as a major downstream effector 
of Lyn in neutrophils during chemotaxis. This inference was further confirmed by effects 
of overexpression of GFP-Rap1A in Lyn-depleted cells. Ectopic expression of Rap1 
nearly completely rescued the defects caused by Lyn depletion (Figure 2.11D). In GFP-
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Rap1 overexpressing cells, the average speed for leading edge protrusion was increased 
to 5.83±0.48 μm/min, and the elongation index was reduced to 1.74 ± 0.21 μm/min 
(mean ± s.e.m.; n=15), even when Lyn was nearly entirely depleted. These values 
approached those of the control cells without Lyn depletion.  
Lyn recruits the CrkL/C3G complex to the leading edge 
Previous studies demonstrated that the Crk family adaptors function downstream 
of activated receptor tyrosine kinases, bind and regulate C3G, a guanine nucleotide 
exchange factor (GEF) for Rap1, and consequently controls Rap1 activation (Arai et al., 
1999; Sattler and Salgia, 1998). We found that human primary neutrophils and dHL-60 
cells express in high abundance Crk-like protein (CrkL), a member of the Crk family. 
Interestingly, Crk-I, expressed in many cell types, was nearly undetectable. We thus 
focused on CrkL and asked whether it was involved in the regulation of Rap1 by Lyn. 
The tyrosine residue Y207, located in the small region between two SH3 domains of 
CrkL, is critical for the regulation of CrkL activity: phosphorylation of Y207 promotes 
intramolecular association of CrkL, leading to inhibition (de Jong et al., 1997; Rosen et 
al., 1995; Senechal et al., 1998). Using a specific antibody, we found that level of 
phosphorylation at Y207 (p-Y207) remained largely unaltered in control cells after fMLP 
stimulation (Figure 2.12A). In contrast, the level of p-Y207 was significantly higher in 
Lyn-depleted cells with and without fMLP stimulation (1.5-2.3 fold over control cells; 
Figure 2.12A). Thus, Lyn modulates the removal of the phosphate group from Y207, 
thereby relieving CrkL inhibition in neutrophils.  
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Lyn is also involved in the regulation of the subcellular localization of CrkL. 
Immunofluorescence of CrkL was distributed diffusely in the cytosol and in the cortical 
areas of the control neutrophils in the absence of fMLP and translocated and accumulated 
at the leading edge, colocalizing with F-actin (Figure 2.12B). C3G exhibited a very 
similar pattern (Figure 2.12C). In contrast, Lyn depletion impaired leading edge 
recruitment of CrkL and C3G (Figure 2.12B,C). Both proteins were located more 
diffusively throughout the cell bodies, even though the cells were morphologically 
polarized. The ratios of mean fluorescence intensity between the leading edge and the 
trailing edge were reduced from 3.41 ± 0.15 to 1.6 ± 0.34 for CrkL and from 2.64 ± 0.13 
to 1.14 ± 0.09 for C3G (mean ± s.e.m.), respectively.  
Consistent with earlier reports, we found that CrkL co-immunoprecipitated with 
C3G in neutrophils. This interaction was detected in resting dHL-60 cells and was 
unaltered after fMLP stimulation. Furthermore, the interaction between CrkL and C3G 
was also detected in Lyn-depleted cells. Thus, Lyn appears unnecessary for the formation 
or the stability of the CrkL/C3G protein complex but is instead essential for its spatial 
organization. 
CrkL is required for Rap1 activation and neutrophil chemotaxis 
We next asked whether CrkL acted upstream of Rap1 in neutrophils during 
chemotaxis. We found that CrkL depletion in dHL-60 cells caused Rap1 activity in 
fMLP-stimulated cells to reduce by 41% (Figure 2.12D). CrkL depletion also caused 
severe chemotactic defects (Figure 2.12E). First, CrkL-depleted cells protruded 
significantly slower (3.01 ± 0.18 μm/min for CrkL shRNA1 and 2.57 ± 0.29 μm/min for 
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CrkL shRNA2 vs. 6.03 ± 0.36 μm/min for cells containing non-targeting shRNAs; mean 
± s.e.m.). Furthermore, 68% (17 of 25 cells examined) developed a stretched elongated 
morphology when responding a point source of fMLP, highly reminiscent of the defects 
of Lyn- and Rap1-depleted cells. In addition, 20% of CrkL-depleted cells failed to 
develop a stable leading edge, similar to cells challenged with high concentrations of IB4 
(Figure 2.7D, Lower panel). Together, these results indicate that Rap1 is a major effector 
of CrkL in neutrophils during chemotaxis. 
2.5 Discussion 
Cell migration is a tightly regulated process that requires adhesion of the extended 
leading edge to the ECM substrate to ensure uninterrupted migration. Although the 
understanding of cell adhesion in slow-migrating mesenchymal cells has been 
significantly improved in the past two decades, this key step remains poorly defined in 
highly polarized and rapidly moving amoeboid cells including neutrophils. Recent studies 
with human neutrophils led to the discovery of signaling pathways essential for the 
establishment of neutrophils’ protrusive leading edge. However, there are significant gaps 
in our understanding of the mechanisms that govern integrin-mediated leading edge 
adhesion during chemotaxis. In this study, we identified a novel signaling mechanism 
that controls localized integrin activation and leading edge adhesion during neutrophil 
chemotaxis. A model is proposed based on these findings, whereby a central regulatory 
role is assigned to the non-receptor tyrosine kinase Lyn (Figure 2.13). In this scenario, 
Gi-dependent Lyn activation and translocation to the leading edge is necessary for the 
relief of inhibition and spatial organization of the CrkL/C3G complex at the leading edge, 
which leads to localized activation of the small GTPase Rap1 and its downstream target 
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β2-integrin. Together, these results provide novel mechanistic insights into a critical but 
poorly studied facet of neutrophil chemotaxis – adhesion of the protrusive leading edge. 
We demonstrated a critical role for Lyn in regulating leading edge adhesion in 
chemotaxing neutrophils. First, in response to chemoattractants, Lyn is activated and 
recruited to leading edge of polarized neutrophils. Depletion of Lyn impairs leading edge 
protrusion but fails to prevent chemoattractant-induced activation of Rac, polymerized 
actin or PI3Ks, suggesting that Lyn regulates leading edge adhesion, not initial 
establishment of the leading edge. Second, although some Lyn-depleted cells exhibit a 
morphological defect similar to that of cells with the backness pathway impaired, Lyn 
depletion does not impair the activity of this pathway. Indeed, a fraction of Lyn-depleted 
cells retract their leading edges when exposed to fMLP, a defect rarely seen in cells with 
the backness pathway inhibited. Moreover, treatment of cells with Y-27632, unlike Lyn 
depletion, fails to impair leading edge protrusion. At the mechanistic level, Lyn depletion 
impairs localized activation of β2-integrin, which appears responsible for the chemotactic 
defects induced by Lyn depletion, because inhibition of de novo leading edge adhesion 
with intermediate concentration of IB4 mimics the phenotype of Lyn-depletion. In 
addition, we identified Rap1, a well-recognized regulator of β2-integrin activity, as a 
major downstream effector of Lyn in neutrophils during chemotaxis.  
How might partial inhibition of leading edge adhesion (e.g., with Lyn or Rap1 
depletion, or the treatment with intermediate dose of IB4) lead to an elongated cellular 
morphology in neutrophils? We speculate that this defect might result from inability of 
the cells to establish firm adhesion sites at the front, a prerequisite for translocation of the 
cell body and de-attachment of the trailing edge. Indeed, in each condition wherein 
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leading edge adhesion is impaired, there is a concomitant reduction in retraction speeds, 
suggesting linkage between front adhesion and tail retraction. Furthermore, inhibition of 
the backness pathway per se (e.g., with Y-27632) does not affect protrusion, again 
implying that compromised retraction in Lyn- and Rap1A-depleted cells, as well as in 
cells treated with intermediated dose of IB4, might originate from defects in leading edge 
adhesion. More complete understanding of the detailed mechanisms underlying the 
morphological defects awaits future experiments. 
In comparison to earlier studies, our findings have provided a more detailed and 
comprehensive delineation of Lyn’s functions in neutrophils during chemotaxis. In 
keeping with earlier studies in Lyn-deficient mouse neutrophils (Pereira and Lowell, 
2003), our data show that without fMLP stimulation, Lyn-depleted cells exhibit enhanced 
adhesion to the fibrinogen substrate and exhibit higher Rap1 activity, suggesting that Lyn 
might inhibit Rap1 activity under this condition. In contrast, in the presence of fMLP, 
Lyn depletion markedly reduces Rap1 activity and consequently impairs local activation 
of β2-integrin in dHL-60 cells. Furthermore, addition of Mn2+, which induces β2-integrin 
activation, causes neutrophils to tightly adhere to the fibrinogen substrate and fail to 
polarize in response to a chemoattractant gradient - a phenotype distinct from Lyn-
depleted cells. Together, these results suggest differential regulation and wiring of the 
chemotactic signaling network in cells with and without attractant stimulation. In 
agreement with this notion, Gakidis et al (Gakidis et al., 2004) showed that Vav1, Vav2 
and Vav3 (GEFs for Rac and Cdc42), are required for integrin-dependent functions of 
mouse neutrophils, including sustained adhesion, spreading, and complement-mediated 
phagocytosis but are dispensable for fMLP–induced signaling events and chemotaxis, 
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even when cells are assessed on the same ECM substrate (Gakidis et al., 2004). Together, 
these results highlight the complexity of chemotactic signaling networks that control 
neutrophil chemotaxis and underscore the importance of studying cell-ECM interactions 
as an integral part of the global chemotactic response. Notably, we did not observe an 
increase in total β2-integrin activity in Lyn-depleted dHL-60 cells after fMLP stimulation 
in suspension (He, Y. and Wang, F., unpublished observations), in contrast to a previous 
study in Lyn-inhibited hematopoietic cells with SDF-1α stimulation (Nakata et al., 2006). 
The differential effects of Lyn depletion/inhibition might be attributed to differences in 
cell types and chemoattractants. Alternatively, it might be that the experiments for the 
detection of active β2-integrin were conducted in suspended cells with prolonged 
incubation with the m24 β2-integrin antibody and fMLP, which did not recapitulate the 
chemotaxis conditions and may also contribute to the variation.  
Our results suggest that the CrkL/C3G protein complex acts as a key signaling 
intermediate that controls Lyn-dependent spatial activation of Rap1 in neutrophils. In this 
scenario, CrkL associates constitutively with the Rap1 GEF C3G, as in hematopoietic 
cells and other cell types. Upon exposure to chemoattractant, the CrkL/C3G complex is 
recruited to the leading edge of polarized neutrophils, providing spatially instructive cues 
for localized Rap1 activation (Fig. 8). Lyn mediates the leading edge recruitment of 
CrkL/C3G, unlikely via direct physical interactions: we did not detect Lyn protein in 
CrkL or C3G immunoprecipitates (He, Y. and Wang, F., unpublished observations). 
Instead, we speculate that other Lyn-interacting proteins such as hematopoietic cell-
specific Lyn substrate 1 (HS1) (Uruno et al., 2003) or the Shc adaptor protein (Ptasznik et 
al., 1995) might play a special role in mediating the recruitment. In addition, we have 
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shown that Lyn modulate CrkL function via the removal of Y207 phosphorylation, 
thereby relieving CrkL's intramolecular inhibition. It is of note that the kinetics of Y207 
phosphorylation differs from Lyn activation: in response to fMLP the level of p-Y207 
remains largely unaltered while Lyn activity is markedly elevated. Therefore, it is not 
clear whether Lyn expression, or its activity, might modulate CrkL Y207 
dephosphorylation. We postulate that the tyrosine phosphatase SH-2 domain phosphatase 
(SHP), reportedly a downstream target of Lyn (Pereira and Lowell, 2003) (Figure 2.13), 
might be responsible for the removal of Y207 phosphorylation. However, although SHP-
1 was recruited to the leading edge of neutrophils, the attempt to produce SHP-1-depleted 
dHL-60 cells failed in our experiments (data not shown). 
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Figure 2.1 Lyn expression and activation. (A) ) Lyn expression in human 
primary neutrophils (1° neutrophil), dHL-60 (dHL-60), non-differentiated HL-
60 (uHL-60) and HEK 293 cells. GAPDH was a loading control. (B) 
Phosphorylation of Lyn in response to fMLP stimulation (100 nM) for various 
time points. (C) Western blot analysis of tyrosine-phosphorylated Lyn (p-Lyn) 
in dHL-60 cells pretreated with buffer, PTX (1 mg/ml, O/N) or LY-294002 (200 
mM, 2 hours) and stimulated with fMLP (100 nM, 1 minute). 
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Figure 2.2 Lyn localization in dHL-60 cells and neutrophils. (A) Immunofluorescence of 
Lyn (red) and F-actin (green) in cells plated on fibrinogen without or with fMLP stimulation 
(100 nM, 2 minutes). Fluorescent images of Lyn (red),  F-actin (green), Lyn/F-actin 
merged images and DIC images of cells are shown. (B) Immunofluorescence studies of 
Lyn (green) and phosphorylated Src (red) in cells plated on fibrinogen with a uniform 
concentration of fMLP (100 nM, 2 minutes). Fluorescent images of Lyn (red), phospho-Src 
(green),  merged images and DIC images of cells are shown. All bars, 10 mm.
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Figure 2.3 Lyn depletion impairs neutrophil chemotaxis toward the fMLP delivered by 
micropipette. (A) Lyn depletion in dHL-60 cells with Lyn-targeting siRNAs or non–specific (NS) 
siRNAs. α-tubulin was a loading control. (B) Immunofluorescence of Lyn in cells transfected 
with NS siRNAs (I) or Lyn siRNAs for 48 hours (II). (C) dHL-60 cells with or without Lyn 
depletion were allowed to migrate toward chemoattractant-containing micropipette (fMLP, 10 
µM) on a fibrinogen-coated substrate. (D) DIC kymographs of a dHL-60 cell transfected with 
control siRNAs, Lyn siRNAs or treated with Y-27632 migrating toward chemoattractant-
containing micropipette (fMLP, 10 µM). The left panel shows a portion of the neutrophils’ leading 
edge under various conditions. The rectangles indicate the regions of the cell used to generate 
the kymographs (before fMLP stimulation). The right panel shows the DIC kymographs. In both 
panels, white arrows indicate the direction of protrusion. Approximately 6 minutes of migration 
was recorded. (E) Speed of leading edge protrusion for control (n = 30) and Lyn-depleted cells 
(n=35) responding to a gradient of fMLP generated by the micropippette. (*, p < 0.001).
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Figure 2.4 Lyn depletion impairs dHL-60 chemotaxis in a microfluidic gradient 
device. (A) Phase-contrast images of control (I, II) and Lyn-depleted cells (I’, II”) in 
the microfluidic chamber coated with the fibrinogen substrate before (I, I’) and after 
(II, II’) exposure to an fMLP gradient (10 minutes) generated by the microfluidic 
device. The gradient can be traced by fluorescent dyes such as fluorescein (left).
Bar, 50 mm. Movies of cells with or without Lyn depletion are available as Movies 
S3 and S4. (B) Enlarged views of control cells (top) and Lyn-depleted cells 
(bottom) 10 minutes after the stimulation of the fMLP gradient. Bar, 10 mm. (F) The 
positions of control and Lyn-depleted cells at the end of the experiments were 
plotted, in relation to their starting position at the origin. X axis shows the distance 
along the fMLP gradient. Y axis shows the distance vertical to the fMLP gradient. 
(C) Speed of leading edge protrusion for control and Lyn-depleted cells responding 
to a gradient of fMLP generated by the microfluidic device. The values are means 
± SEM (n = 47 for control, 46 for Lyn-depleted cells).
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Figure 2.5  Kinase activity is required for the regulation of neutrophil chemotaxis by Lyn. 
(A) Expression of Lyn-EGFP or LynKD-EGFP in Lyn-depleted cells. Lyn-depleted cells 
were differentiated and transfected with GFP-tagged wild-type Lyn56 or kinase-dead 
dominant negative mutant of Lyn56 (K275D) containing silent mutations in the shRNA-
targeting region. Cell lysates were analyzed for Lyn. GAPDH is the loading control. (B) 
Wild-type Lyn, but not kinase-dead (K275D) Lyn mutant, rescues the defects of Lyn-
depleted cells. Time-lapse images of representative cells for both conditions are shown. 
Bar, 10 μm. (C) Speed of leading edge protrusion for control, Lyn-depleted, Lyn rescued 
cells in micropipette assay. The values are means ± SEM. The asterisk indicates that the 
cells differ statistically from the control cells (*, p < 0.001)
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Figure 2.6 Lyn depletion does not affect frontness pathways. (A) dHL-60 cells with or 
without Lyn depletion were stimulated for indicated times and lysed. Akt phosphorylation 
(Thr308) was assessed by western blotting. Representative blots for phospho- and total 
Akt are shown. (B) Quantification of Rac-GTP in dHL-60 cells with or with Lyn depletion. 
Cells were stimulated with fMLP (100 nM) for times indicated and lysed. The level of 
Rac-GTP was determined by the use of an absorbance-based Rac G-LISA kit. The y 
axis represents the absorbance at 490 nm. Each bar represents the mean ± s.e.m. 
(error bars) (n=4). (C) Quantification of F-actin polymerization. Cells with or without Lyn 
depletion were stimulated with fMLP (100 nM) for various times in suspension and fixed 
for staining with rhodamine-phalloidin. Fluorescence in stained cells was determined by 
flow cytometry. Values are mean ± s.e.m. (n = 4).
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Figure 2.7(cont.) Lyn depletion attenuates β2-integrin activation at the leading 
edge. (A) Immunofluorescence of β2-integrin (red) in cells with or without Lyn 
depletion, stimulated with a uniform concentration of fMLP (100 nM, 2 minutes). 
Fluorescent images of F-actin (green), F-actin/β2-integrin merged images and DIC 
images of cells are also shown. Bar, 10 mm. (B) Immunofluorescence of active β2-
integrin (red), stained by antibody m24, in cells with or without Lyn depletion, 
stimulated with a uniform concentration of fMLP (100 nM, 2 minutes). Fluorescent 
images of F-actin (green), F-actin/active β2-integrin merged images and DIC 
images of cells are also shown. Bar, 10 mm. (C) Front vs back ratio of fluorescence 
intensity in (A) and (B). The region containing actin staining is defined as front, 
while the rest of the cell is defined as back. Fluorescence intensity in the regions of 
front and back was quantified by Image J. The ratios for control cells (37 cells for 
total β2-integrin and 45 cells for active β2-integrin) and Lyn-depleted cells (53 cells 
for total β2-integrin and 46 for active β2-integrin) were calculated. (D) Blocking front 
de novo adhesion mimics the defects of Lyn depletion in chemotaxis. Time lapse 
images from four representative experiments are shown.
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Figure 2.8 impaired chemotaxis of Lyn depleted cells is not due to altered global adhesion. 
(A) dHL-60 cells with or without Lyn depletion were plated on fibrinogen in the absence or 
presence of β2-integrin function-blocking antibody (IB4, 1 µg/ml), not stimulated or 
stimulated by fMLP (100 nM, 30 min). After four washes the degree of cell adhesion was 
assessed. Values were normalized to adhesion in control cells without fMLP or IB4 (=1) and 
are means±SEM (n=4). (B) Flow cytometry analysis of surface expression of β2 integrin in 
control and Lyn-depleted cells after fMLP stimulation (100 nM, 10 min). The black line 
indicates background fluorescence from the isotype control IgG. (C) Time-lapse images of 
cells treated with Mn2+ (0.2 mM, 20 min) and exposed to the point source of fMLP from a 
micropipette for indicated times. Bar, 10 mm. A typical experiment from six independent 
experiments is shown. (D) Immunofluorescence studies of active β2-integrin (red) in cells 
with Mn2+ (0.2 mM, 20 min) and thereafter stimulated with a uniform concentration of fMLP 
(100 nM, 2 minutes). Fluorescent images of F-actin (green), F-actin/active β2-integrin 
merged images and DIC images of cells are also shown. Bar, 10 mm
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Figure 2.9 The backness pathway is not altered in Lyn depleted cells. (A) 
Quantification of RhoA-GTP in dHL-60 cells with or with Lyn depletion, not 
stimulated or stimulated with fMLP (100 nM, 2 min). Each bar represents the 
mean±SEM (error bars) (n=4). (B) Western blot analysis of activated myosin II 
(p-MLC) in control cells, Lyn-depleted cells and cells treated with Y-27632 (10 
μM, 30 min). All cells were stimulated or not stimulated in fMLP (100 nM) for 2 
min in suspension, and the cell lysates were subjected to SDS-PAGE analysis. A 
typical experiment from four separate experiments is shown. Myosin heavy chain 
(MHC) was used as a loading control. (C) Merged fluorescent images of p-MLC 
(red) and F-actin (green) in control, Lyn-depleted cells and cells pretreated with 
Y-27632 (30 μM, 30 min). The corresponding DIC images are shown. The white 
arrow indicates the loss of p-MLC fluorescence at the back of the Y-27632-
treated cell. Bars, 10 μm.
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Figure 2.10 Lyn is required for Rap1 activation and translocation to the leading edge. 
(A) The levels of Rap1-GTP in dHL-60 cells under various conditions. dHL-60 cells with 
or without Lyn depletion were stimulated with 100 nM of fMLP for various time points 
and lysed for the pull-down assay. Levels of total Rap1 and GAPDH were used to show 
cell lysate input. The blot for Lyn is also shown. (B) Quantification of relative levels of 
Rap1-GTP level in dHL-60 cells with and without Lyn depletion 30 seconds after fMP
stimulation. Each bar represents the mean±SEM (error bars). Values are normalized to 
the level of Rap1-GTP (=1) in cells without Lyn depletion. (*, p<0.001). (C) dHL-60 cells 
with or without Lyn depletion were transfected with EGFP-RalGDS and stimulated by a 
fMLP-containing micropipette for indicated times. EGFP-RalGDS fluorescence and the 
corresponding DIC images are shown. (D) Enlarged views of EGFP-RalGDS-
expressing cells with or without Lyn depletion after stimulation with fMLP. The arrow 
indicates leading edge recruitment of EGFP-RalGDS.
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Figure 2.11 (cont.) Rap1A depletion mimics the chemotactic defects of Lyn 
depletion. (A) Western blotting of Rap1A in dHL-60 cells with or without shRNAs
targeting Rap1A. GAPDH is a loading control. (B) dHL-60 cells with Rap1A 
depletion(Rap1 A shRNAs) or without (Control, with non-targeting shRNAs) 
stimulated on a fibrinogen-coated substrate by a point source of fMLP. The four 
images in each row show the positions of individual cells after exposure to fMLP. (C) 
Speed of leading edge protrusion for control and Rap1A-depleted cells in the 
micropipette assay. The values are means ± SEM. The asterisk indicates that the 
Rap1A-depleted cells differ statistically from the control cells (*, p < 0.001) (D) dHL-
60 cells with or without Lyn depletion were transfected with EGFP-Rap1A and 
stimulated with a fMLP-containing micropipette. All bars, 10 μm.
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Figure 2.12 (cont.) Lyn is required for the functions of CrkL/C3G complex in 
neutrophils. (A) Western blotting of phosphorylated CrkL (p-CrkL, at Y207) in dHL-60 
cells with or without Lyn depletion. Cells were unstimulated or stimulated in 
suspension with 100 nM fMLP for various times. CrkL and α-tubulin were loading 
controls. Lyn expression was also analyzed. (B and C) Immunofluorescence of CrkL
and C3G in dHL-60 cells with or without Lyn depletion. Cells were stimulated with a 
uniform concentration of fMLP (100 nM, 2 minutes). Immunofluorescence of CrkL in 
human primary neutrophil is also shown. (D) Levels of Rap1-GTP in dHL-60 cells with 
or without CrkL depletion 30 seconds after fMLP stimulation. 30 seconds of fMLP
stimulation gave rise to maximal Rap1 activation . Blot for total Rap1 shows input 
from cell lysates for each condition. Blots for CrkL and C3G are also shown. (E) dHL-
60 cells with or without CrkL depletion were stimulated with a micropipette containing 
fMLP. The images in each row show the positions of individual cells (identified with a 
superimposed letter) after exposure to fMLP. All bars, 10 μm.
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Figure 2.13 A biochemical pathway is required for leading edge adhesion, 
localized b2-integrin activation and persistent migration in neutrophils during 
chemotaxis. Lyn is a activated downstream effector of ligated GPCR and 
translocated to leading edge. Active Lyn then recruits and activates CrKL/C3G 
complex, which further spatially activate Rap1 in the leading edge. Activated 
Rap1 up-regulates β2 integrin and enhances the front adhesion of chemotactic 
neutrophils. GPCR: G-protein coupled receptor.
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CHAPTER 3 MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2 
(mTORC2) REGULATES ACTIN POLYMERIZATION AND NEUTROPHIL 
CHEMOTAXIS 
3.1 Summary 
Chemotaxis allows neutrophils to seek out sites of infection and inflammation. 
The signaling mechanism underlying neutrophil polarity and chemotaxis has been 
intensively studied and is still not fully understood. The asymmetric accumulation of 
filamentous actin in the leading edge is essential for the development and maintenance of 
neutrophil polarity and has been postulated as the driving force for neutrophil motility. 
By using RNA interference, pharmacological and biochemical approaches, we 
demonstrated that mTORC2 is an essential regulator of actin cytoskeleton in neutrophils 
and mTORC2 is required for neutrophil chemotaxis. Depletion of mTORC2 impaired 
chemotaxis of dHL-60 cells, a neutrophil-like cell line. Although depletion of mTORC2 
abolished AKT phosphorylation, a downstream event of mTORC2 activation, inhibition 
of AKT phosphorylation failed to recapitulate the migratory defect of mTORC2 depletion 
in both dHL-60 cells and neutrophils. Furthermore, inhibition of kinase activity of 
mTORC2 also failed to alter neutrophil chemotaxis. At the molecular level, mTORC2 
depletion severely impaired actin polymerization induced by chemoattractant stimulation. 
Consistent with this finding, mTORC2 depletion reduced chemoattractant-induced Rac 
activation under both adherent and non-adherent conditions.  We propose here that 
mTORC2 regulates neutrophil chemotaxis through Rac-mediated signal pathways.  
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3.2 Introduction 
  Neutrophils are critical for the host innate immune response against invading 
microbes. Chemotaxis, the directed movement of cells, allows circulating neutrophils in 
the bloodstream to crawl toward sites of infection and inflammation. Upon stimulation by 
chemoattractants, neutrophils respond by establishing a leading edge (pseudopod), which 
protrudes toward the source of the chemoattractant, and a trailing edge (uropoda), which 
faces away from the chemoattractant gradient. Recently work has begun to unfold the 
mechanism underlying the polarity and chemotaxis of neutrophils. In the leading edge, 
signaling pathways, including PI3Kγ and Rac, control actin polymerization for membrane 
protrusion (Sasaki et al., 2000; Weiner et al., 2002; Weiner et al., 1999). RhoA-regulated 
actin-myosin contractility is responsible for the retraction of the trailing edge (Xu et al., 
2003). The asymmetric accumulation of filamentous actin (F-actin) in the leading edge is 
the hallmark of neutrophil polarity and also has been postulated to provide the driving 
force for neutrophil chemotaxis. Thus, the delineation of signaling pathways regulating 
actin polymerization induced by chemoattractants is the key for better understanding the 
molecular mechanism underpinning neutrophil polarity and chemotaxis. 
mTORC2 has emerged as the key regulator for actin cytoskeleton in mammalian 
cell lines (Jacinto et al., 2004; Sarbassov et al., 2004). In contrast to mTORC1 in 
mammals, which has been intensively studied for many years and shown to be the key 
regulator for cell growth in response to nutrient signals, the functions of mTORC2 remain 
elusive (Jacinto and Hall, 2003; Loewith et al., 2002). In budding yeast, Torc2 has been 
shown to be resistant to rapamycin treatment and regulates bud formation (Loewith et al., 
2002). Recently the counterpart of yeast Torc2 in mammals, mTORC2, has been 
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identified in mammals and is also insensitive to rapamycin treatment (Jacinto et al., 2004; 
Sarbassov et al., 2004). Depletion of mTORC2 in HeLa cells and 3T3 fibroblasts 
disrupted stress fibers and dramatically altered the structure of actin cytoskeleton. 
Attempts to generate rictor knockout mice failed due to embryonic lethality (Guertin et 
al., 2006; Shiota et al., 2006). In Dictyostelium discoideum, homologues of mTORC2 
components have been identified: LST8, RIP3 (AVO1) and Pia (AVO3, mAVO3, Rictor) 
(Cai et al., 2010; Lee et al., 2005). The deletion of TORC2 did not affect survival, but 
impaired D. discoideum chemotaxis induced by cAMP. TORC2 acted downstream of Ras 
and regulates PKBR1 and PKBA phosphorylation which was required for actin 
polymerization in D. discoideum chemotaxis (Cai et al., 2010). The embryonic lethality 
of mTORC2 has hampered studies of mTORC2 functions in mammalian tissues and 
cells, including neutrophils. During preparation of our paper, a study with Rictor 
depletion in PBL cell line showed that mTORC2 is required for neutrophil chemotaxis by 
regulating cAMP production and RhoA activation (Liu et al., 2010). Interestingly, the 
actin polymerization in cells with mTORC2 depletion is shown to be comparable to the 
control in their report.  
Here by using a more commonly used neutrophil-like cell line HL-60 cell, we 
reported that mTORC2 depletion impaired neutrophil chemotaxis through disrupting the 
reorganization of actin cytoskeleton. mTORC2 was required for fMLP-induced actin 
polymerization and motility of neutrophils. Importantly, this requirement was not 
dependent on kinase activity of mTOR and the downstream event of AKT 
phosphorylation. Furthermore, we showed that mTORC2 depletion inhibited Rac 
activation, which is required for actin polymerization during neutrophil chemotaxis.    
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3.3 Materials and methods 
 Reagents and plasmids 
Human fibrinogen, human serum albumin (HSA) and fMLP were from Sigma-
Aldrich. Rapamycin, Y27632 and Akti1/2 were from Calbiochem. Torin1 was kindly 
provided by Drs. Nathanael S. Gray (Dana-Farber Cancer Institute, Harvard) and David 
M. Sabatini (Whitehead Institute, MIT). Rabbit anti-Rictor antibody and Rictor blocking 
peptide were from Bethyl laboratories (Montgometry, TX). Rabbit anti-mTOR antibody, 
rabbit anti-Raptor antibody, rabbit anti-Akt antibody, mouse anti-phospho [Ser473] and 
rabbit anti-phospho [Thr308]-Akt antibodies, mouse anti-phospho [Thr389]-S6K1, rabbit 
anti-phospho [Ser19] myosin light chain antibody, were from Cell Signaling Technology. 
Alexa fluor 488 phalloidin, alexa fluor 647 phalloidin and alexa fluor 594 conjugated 
secondary antibodies were from Invitrogen. Goat anti-GAPDH polyclonal antibody was 
from GenScript. All secondary antibodies for western blotting were from Jackson 
ImmunoResearch Laboratories. Other reagents if not mentioned specifically were from 
Sigma. 
Three shRNA constructs targeting human mTOR were from Sigma [SHCLNG-
NM_004958:TRCN0000039783,TRCN0000039784 and TRCN0000039785).Two 
shRNA constructs targeting human Raptor (id # 1857 and 1858 ) or Rictor (id # 1853 and 
1854) were requested from Addgene.    
 
 
 
80 
 
Cell culture, lentiviral production and infection 
Cultivation and differentiation of HL-60 cells were described previously (Wang et 
al., 2002a). HL-60 cells stably expressing Actin-YFP were from Dr. Henry Bourne lab 
(University of California at San Francisco). 
For lentiviral production, shRNA-containing plasmids were co-transfected with 
three packaging plasmids pPL1, pPL2 and pPL/VSVG (Invitrogen) into actively growing 
HEK293T cells. After 3 days of transfection, supernatant containing the lentiviral 
particles was concentrated by Lenti-X concentrator (Clontech) and added to growing HL-
60 cells in the presence of 6 μg/ml polybrene for 18-24 hours. Infected cells were 
transferred to fresh culture medium containing 1.3% DMSO and 0.25 µg/ml puromycin 
and differentiated for 4-5 days. 
Immunofluorescence and live-cell imaging 
For immunofluorescence studies, cells were suspended in  mHBSS buffer (20 mM 
HEPES, pH 7.4, 50 mM sodium chloride, 4 mM potassium chloride, 1 mM magnesium 
chloride, 10 mM glucose) with 1% HSA, and then plated on fibrinogen-coated cover 
glass (250 μg/ml fibrinogen) (Schymeinsky et al., 2005) for 20 minutes, washed briefly 
and subsequently stimulated with a uniform concentration of 100 nM fMLP for indicated 
times. After stimulation, cells were immediately fixed with 3.7% paraformaldehyde in 
CSK buffer (10 mM HEPES, pH 7.4, 138 mM KCl, 3 mM MgCl2, 2mM EGTA, 150 mM 
sucrose) for 15 minutes, washed and permeablized for 10 minutes by using CSK buffer 
containing 0.2% Trinton X-100. Cells were blocked in CSK buffer containing 1% BSA 
for 1 hour, incubated with primary antibodies overnight at 4°C followed by Alexa fluor 
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594 conjugated goat anti-rabbit or anti-mouse secondary antibody. Primary antibodies 
were used at dilutions of 1:100 (Rictor) and 1:200 (p-MRLC). Secondary antibodies were 
used at 2 μg/ml. For the detection of F-actin, cells were incubated with Alexa fluor 488- 
conjugated phalloidin for 10 minutes at RT. 
For live-cell imaging, cells were plated on human fibrinogen-coated surface for 
20 minutes, washed briefly, and subsequently stimulated with a point source of 10 µM 
fMLP from a micropipette (internal diameter of 1 µm, pulled from a glass capillary), as 
described (Servant et al., 2000a). DIC images, fluorescent images and combined 
DIC/fluorescence images were collected with a Zeiss 40X NA 1.30 Fluar DIC objective 
or 63X NA 1.4 Plan Apochromat DIC objective on a Zeiss Axiovert 200M microscope. 
All images were collected with a cooled charge-coupled device camera (AxioCam MR3, 
Zeiss) and processed by the Image J program. 
Western blotting 
Cells (5 x 10
6) were suspended in 90 μl of mHBSS buffer and stimulated with 10 
μl of 1 μM fMLP for various times. fMLP stimulation was terminated by the addition of 
equal volume of 2 x RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% NP-40, 150 mM NaCl, 1 
mM EDTA) containing 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF and a protease inhibitor 
cocktail (Sigma). Cell lysates were clarified by centrifugation at 14,000 x g for 10 
minutes. Protein concentrations of the lysates were determined by using DC Protein 
Assay Kit (Bio-Rad). Equivalent amounts of protein (20 μg) were resolved on a 8% 
disulfide-reduced SDS-PAGE gel, transferred to Trans-Blot Transfer Medium, blocked 
with 5% nonfat milk in TBST for 1 hour at room temperature, and incubated with the 
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primary antibody O/N at 4°C followed by a secondary antibody conjugated to 
horseradish peroxidase (HRP; GE Healthcare). The HRP signals were detected by using 
enhanced chemiluminescence (SuperSignal West Pico). The western blot was stripped 
and re-probed with appropriate antibody according to the manual (Restore Western Blot, 
Thermo Scientific). 
Microfluidic gradient device 
The microfluidic gradient device comprises of a polydimethylsiloxane (PDMS) 
slab embedded with a Y-shaped fluidic channel and glass substrate as its base. The 
microchannels were fabricated using rapid prototyping and soft lithography as described 
previously (Herzmark et al., 2007; Jeon et al., 2000; Lin and Butcher, 2006).  Cells were 
washed, suspended in mHBSS containing 1% HSA and injected in the microfluidic 
device. The device was left in the incubator (37°C, 5% CO2) for 20 minutes to allow 
cells to attach to the substrate. The channels were then gently rinsed with mHBSS to 
wash away floating cells 
To generate soluble gradients, fMLP (500 nM) and mHBSS were infused into the 
device from separate inlets. Solutions were driven using a syringe infusion pump (Pump 
22, Harvard Apparatus) at a flow rate of 0.03 ml/h to generate a concentration gradient in 
the channel by diffusion. Phase contrast images were captured using Axiovision software 
on a Zeiss Axiovert 200M microscope. 
Actin polymerization assay 
The procedure for measuring polymerized actin was according to previous report 
with some modifications (Weiner et al., 2006). Briefly, 1×10
6
 cells were starved in 
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serum-free medium for 1 hour at 37°C and suspended in mHBSS buffer. Cells were 
stimulated with 100 nM fMLP for indicated times. After stimulation, cells were fixed by 
adding equal volume of 7.4% paraformaldehyde for 30 minutes at room temperature. 
Fixed cells were permeabilized and stained in PBS buffer containing 0.1% Triton X-100 
and Alexa 647-conjugated phalloidin (1:100) for 30 minutes at 37°C in dark. Stained 
cells were washed once and suspended in ice-cold PBS, and fluorescence was 
immediately determined by flow cytometry with a BD Biosciences LSR II System. The 
mean fluorescence intensity of the cell population was determined. 
Rac pull-down assay 
GST (glutathione S-transferase) – PAK1 – PBD (p21-binding domain) fusion 
protein was prepared according to previous report (Benard et al., 1999). dHL-60 cells (5 
× 10
6
 cells) containing NT shRNA or Rictor shRNA were starved in serum-free medium 
for 1 hour at 37°C. Cells were then suspended in mHBSS buffer and stimulated by 100 
nM fMLP for indicated times. Cell stimulation was stopped by adding 0.4 ml 1.25 × lysis 
buffer(1× lysis buffer: 25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1% NP-
40, and 5% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 mM Diisopropyl 
phosphorofluoridate, and protease inhibitor). Cell lysates were immediately put on ice 
and pipetted for 4-5 times. The Subsequent steps were performed as previous description 
(Benard et al., 1999). For adhesion condition, cells were plated on fibrinogen (100 µg/ml) 
coated 6-well plates for 30 minutes and then stimulated with 100 nM fMLP for indicated 
times. Cells including adherent and non-adherent were lysed, and the same procedures as 
above mentioned were performed to pull down the activated Rac.    
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RhoA activation assay 
An absorbance-based (490 nm) RhoA G-LISA kit (Cytoskeleton, Inc) was used to 
determine RhoA-GTP levels in dHL-60. Cells with or without Rictor depletion were 
suspended in mHBSS (5 × 10
6
 cells in 90 μl per condition), and stimulated or 
unstimulated with 10 μl of 1 μM fMLP. The reaction was stopped by adding 100 μL of 2 
× lysis buffer (provided with the kit) at 4°C. Subsequent steps were performed as 
described in the protocol attached to the kit. For adhesion condition, cells were plated on 
fibrinogen (100 µg/ml) coated 6-well plates for 30 minutes and then stimulated with 100 
nM fMLP for indicated times. Cells including adherent and non-adherent were lysed, and 
the same procedures as described in the kit were performed to determine RhoA activity. 
 Isolation of primary neutrophils 
Primary neutrophils were isolated from venous blood from healthy human donors. 
Blood was collected into heparin-containing Vacutainer tubes (BD Biosciences) and 
neutrophil isolation procedure was performed within 30 minutes of blood collection using 
PMN isolation medium (Matrix). Red blood cell contaminants were removed by Red 
Blood Cell Lysis buffer (Roche), which produced more than 97% of neutrophil purity. 
Neutrophils were suspended in RPMI 1640 medium supplemented with 10% fetal bovine 
serum at 37°C until the time of experiments conducted within 8 hours after isolation. 
Statistical analysis 
Statistically significant differences between two groups were determined using 
the heteroscedastic two-tailed Student’s t-Test. The difference with p value less than 0.05 
is considered to be significant. 
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3.4 Results 
mTORC2 is required for neutrophil chemotaxis 
To explore the role of mTOR signaling in neutrophil chemotaxis, we assessed the 
effects of mTORC1 and mTORC2 depletion on neutrophil chemotaxis (Figure 3.1 and 
Figure 3.2). A human promyelocytic leukemia cell (HL-60), which can be differentiated 
into neutrophil-like cells in the presence of DMSO and is genetically tractable, has been 
widely used as a model for studying neutrophil chemotaxis (Bodin and Welch, 2005; 
Hauert et al., 2002; Nuzzi et al., 2007; Schymeinsky et al., 2005; Servant et al., 2000b; 
Weiner et al., 2006). We identified that both HL-60 cells (uHL-60) and differentiated 
HL-60 cells (dHL-60) expressed components of mTOR complexes, mTOR, Rictor and 
Raptor (Figure 3.1A). The expression of mTOR, Rictor and Raptor in human primary 
neutrophils was confirmed in this study.  
By using a lentiviral transfection system, we were able to transiently knock down 
the expression of genes of interest in dHL-60 cells, which allows us to quickly test gene 
function in dHL-60 cell chemotaxis. HL-60 cells were incubated with lentivirus overnight 
and subsequently differentiated for 4-5 days. In contrast to non-target shRNA, shRNAs 
for mTOR, Raptor and Rictor efficiently knocked down their respective proteins (Figure 
3.1B-C). Protein levels were reduced after the introduction of appropriate shRNAs: 
mTOR shRNA-1, 36.3% ± 4.1 %; mTOR shRNA-2, 20.8% ± 2.8 %, mTOR shRNA-3, 
5.9% ± 5.0 %; Raptor shRNA-1, 21.4% ± 5.2%; Raptor shRNA-2, 13.4% ± 3.8%; Rictor 
shRNA-1, 17.1% ± 9.1 %; Rictor shRNA-2, 15.2% ± 7.8 %. The chemotactic behaviors 
of mTOR, Raptor or Rictor-depleted cells were examined by using a microfluidic 
gradient device, which enabled us to watch populations of cells moving in a highly stable 
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gradient over a long distance (150 µm). Time-lapse video-microscopy was used to track 
individual cells as they migrated in the microfluidic chamber. In this assay, a majority of 
cells with non-target shRNA (70.6% ± 3.8%) and Raptor shRNAs (Raptor shRNA-1, 
69.4% ± 4.8%; Raptor shRNA-2, 69.1% ± 7.9%) polarized and moved toward the 
concentration gradient (1.4 nM/μm) of the bacteria-derived chemoattractant formyl-Met-
Leu-Phe (fMLP),  resulting in  few cells in the low concentration region of the chamber 
(Figure 3.2A-D). As shown in the cell trajectory, most control cells or cells with Raptor 
knockdown developed typical polarized morphology during chemotaxis, exhibiting a flat 
broad front and a narrow tail (Figure 3.2C). In contrast, cells with mTOR or Rictor 
depletion showed severe defects in chemotaxis (Figure 3.2A-D). Few cells migrated 
toward the gradient of fMLP (mTOR shRNA-2, 22.1% ± 7.0%; mTOR shRNA-3, 11.9% 
± 3.2%; Rictor shRNA-1, 9.3% ± 1.1%; Rictor shRNA-2, 12.9% ± 5.0%) and remained 
in the lower concentration region of the chamber. At the end of stimulation, most cells 
with mTOR or Rictor depletion failed to develop polarized morphology (Figure 3.2B). 
These cells randomly extended small protrusions along the membrane (Figure 3.2C). The 
chemotactic behaviors of cells treated with shRNAs were also analyzed in a point source 
of fMLP gradient delivered by a micropipette (Figure 3.2E). Similarly, cells with mTOR 
or Rictor depletion failed to migrate toward the tip. Taken together, mTORC2, not 
mTOC1, regulated chemotaxis in dHL-60 cells.  
TOR signaling pathways play an essential role in cell growth. To assess whether 
the migratory defect of cells with mTOR or Rictor depletion is due to the non-specific 
toxicity of protein depletion, we examined the percentage of apoptotic cells in 
differentiated cells transfected by shRNAs (Figure 3.3). Rictor depletion (Rictor shRNA-
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1) in dHL-60 did not increase apoptotic cells within 4-5 days when compared to control, 
although mTOR depletion caused an increase of apoptotic cells (Figure 3.3A). In 
addition, the differentiation process to neutrophils, indicated as the expression level of 
beta 2 integrin, appeared to be unaffected in Rictor depleted cells. However, the depletion 
of mTOR kinase dramatically reduced the expression of beta 2 expression (Figure 3.3B). 
Furthermore, AKT phosphorylation (pT308), a downstream event of fMLP-induced PI3K 
activation, was not affected in cells with Rictor depletion (data not shown).   
mTORC2-dependent AKT phosphorylation is not required for neutrophils chemotaxis 
mTORC2 is  the key kinase that phosphorylates a serine site (S473) at the 
hydrophobic motif of AKT in response to nutrient signals (Sarbassov et al., 2005). In 
budding yeast, TorC2 regulates actin polymerization through the ACG kinase YPK2, the 
yeast AKT homologue (Kamada et al., 2005; Schmidt et al., 1996). Similarly, TORC2 in 
D. discoideum activates PKBR1 and PKBA, the Dictyostelium AKT homologue, in the 
leading edge of cells, and plays an important role in the regulation of actin cytoskeleton 
and chemotaxis (Kamimura et al., 2008; Lee et al., 2005). To examine whether the 
mTORC2-AKT signaling pathway plays a similar role in neutrophil chemotaxis, we 
examined the phosphorylation of AKT in neutrophils stimulated by fMLP, and how the 
inhibition of AKT phosphorylation affected neutrophil chemotaxis (Figure 3.4).  
Differentiated HL-60 cells and human primary neutrophils were stimulated with 
fMLP in suspension, which excluded the influence of extracellular substrate interaction. 
The endogenous level of phosphorylated AKT was assessed by using a specific antibody 
for p-AKT (Ser473). Exposure of suspended dHL-60 cells (i.e., in the absence of ECM 
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attachment) to the fMLP induced rapid and robust phosphorylation of AKT, reaching a 
maximum at 60 seconds, as detected by the phospho-specific antibody (Figure 3.4A-B). 
A similar pattern of AKT phosphorylation was also observed in human primary 
neutrophils after fMLP stimulation, although the peak of phosphorylation happened at a 
later time (data not shown). Rictor depletion, which specifically disrupts mTORC2, 
abolished AKT phosphorylation at serine 473 (Figure 3.4C). The level of AKT 
phosphorylation at serine 473 in Rictor-depleted cells was reduced to 12.4 % ± 11.2% of 
control cells at the stimulation time point of 1 minute (Figure 3.4D). In contrast, the 
phosphorylation of AKT at theorine 308, which is catalyzed by PDK1, was not altered in 
Rictor-depleted cells (data not shown). This result suggested that in neutrophil-like cells, 
dHL-60 cells, mTORC2 is also the major regulator for AKT phosphorylation at serine 
473. To ask whether the inhibition of AKT phosphorylation at serine 473 is responsible 
for the migratory defect observed in Rictor depleted cells, like the case in Dictyostelium, 
we used a specific inhibitor Akti-1/2, shown to abolish the phosphorylation at both sites 
in vitro and in vivo (Barnett et al., 2005), to test whether the inhibition recapitulates the 
chemotactic defect of cells with mTORC2 depletion. We observed the potent inhibition 
of AKT phosphorylation at both sites even at low concentration of Akti-1/2 (0.1 µM) 
(Figure 3.4E). However, pretreatment of Akti-1/2 had no effect on chemotaxis of dHL-60 
cells and human primary neutrophils in the gradient of fMLP generated by microfluid 
device (Figure 3.4F and data not shown). In the micropipette migration assay, Akti-1/2 
treated dHL-60 cells moved toward the micropipette tip with a similar polarized 
morphology and speed comparable to control cells (data not shown).  These data indicate 
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that AKT phosphorylation is not the essential downstream event of mTORC2-mediated 
pathway in the regulation of neutrophil chemotaxis. 
mTORC2 regulates neutrophil chemotaxis through kinase activity- independent pathways 
Since AKT phosphorylation at serine 473 was not involved in mTORC2-mediated 
signaling pathway regulating neutrophil chemotaxis, what would be the downstream 
targets for this mTORC2-mediated pathway? Rapamycin, a potent and specific inhibitor 
for mTORC1, has been shown to inhibit many signaling pathways of mTORC1, although 
some rapamycin insensitive activities have been reported  in mTORC1 (Wullschleger et 
al., 2006). Recently Torin1, an ATP analogue for mTOR kinase, has been developed. 
Exposure of cells to Torin 1 inhibits a variety of mTORC1 and mTORC2 activities 
(Thoreen et al., 2009). To further understand whether other kinase activities of mTORC2, 
instead of AKT phosphorylation, are responsible for the regulation of neutrophil 
chemotaxis by mTORC2, we examined the effects of Torin 1 treatment on neutrophil 
chemotaxis (Figure 3.5). In this study, we also included the rapamycin treatment as a 
comparison.  
Rapamycin treatment reduced S6K1 phosphorylation (1 minute time point: 
control, 88.8% ± 11.2%; rapamycin, 20.5% ± 14.3%; Means ± s.e.m), while there was no 
effect on AKT phosphorylation (Figure 3.5A-C). In contrast, Torin 1 treatment reduced 
the phosphorylation level of both S6K1 and AKT(p-T389 S6K1: control, 88.8% ± 11.2%; 
torin 1, 12.6% ± 6.8%. p-S473 AKT: control, 93.5% ± 6.5%; torin 1, 12.6% ± 6.8%. 1 
minute time point) (Figure 3.5A-C). Furthermore, Torin1 also inhibited AKT 
phosphorylation induced by fMLP in isolated human primary neutrophils (data not 
90 
 
shown). Next we assessed the effects of these inhibitor treatments on neutrophil and 
dHL-60 chemotaxis by using the microfluid device. Both rapamycin and Torin 1 had no 
detectable effect on chemotaxis of dHL-60 and neutrophils (Figure 3.5D,E and data not 
shown).  Both the speed and chemotaxis index of rapamycin or torin 1-treated cells were 
comparable to those of control cells (Table 1). These data indicated that mTOR kinase 
activity was not required for mTORC2-mediated signaling pathway regulating neutrophil 
chemotaxis. 
mTORC2 accumulation in the leading edge of chemotactic neutrophils  
After chemoattractant stimulation, neutrophils respond by establishing the 
polarity with asymmetric accumulation of signaling molecules in the leading edge or 
trailing edge: PI3Ps, active Rac and filamentous actin accumulate in the leading edge 
(Wang, 2009); RhoA and actin-myosin accumulate in the trailing edge (Xu et al., 2003). 
The spatial distribution of these molecules indicates their distinct functions in neutrophil 
polarity and chemotaxis. In D. discoideum, TORC2 has been postulated to activate 
PKBR1 and PKBA in the leading edge (Kamimura et al., 2008). To explore the 
mechanism of mTORC2 regulation of neutrophil chemotaxis, we examined the cellular 
localization of mTORC2 before and after fMLP stimulation by Rictor immuno-staining. 
At the resting condition, Rictor concentrated in the nuclear region of dHL-60 cells with a 
little accumulation at the surrounding region beneath the membrane. In the same cells, 
filamentous actin accumulated at the membrane cortical region (Figure 3.6A, top panel). 
After 3 minutes of uniform fMLP exposure, we observed an accumulation of Rictor in 
the leading edge, co-localizing with F-actin (Figure 3.6A, Middle panel).  The 
fluorescence intensity of stained Rictor and F-actin across the body was revealed in the 
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line scanning profile (Figure 3.6B). We defined the first 4 microns of leading edge as the 
“front” and the remaining cell body as the “back”. The fluorescence intensity ratio of 
front vs back was 1.89 ± 0.09 (Mean ± s.e.m) (Figure 3.6C). The specificity of Rictor 
staining was further confirmed by the control experiment with blocking peptide (Figure 
3.6A, the low panel). 
The co-localization of Rictor and F-actin in the leading edge of cells raised the 
question of whether they directly associated with each other. We used a biochemical 
approach to ask whether Rictor or mTORC2 directly associate with filamentous actin. 
Resting and stimulated dHL-60 cells were lysed in Triton X-100 lysis buffer with 
different concentrations of Triton x-100 (1% vs 0.1%). In control experiments, a large 
proportion of Rictor was released into the soluble fraction of cell lysate, independent of 
the concentrations of detergent used. After stimulation, we observed an increased 
proportion of actin retained in the insoluble fraction. Treatment with Latrunculin B 
completely eliminated the actin from the insoluble fraction of the cell lysate, suggesting 
that actin polymerization was inhibited in cells. However, the protein level of Rictor in 
Triton-X 100 insoluble pellet was not altered by the treatment of Latrunculin B. This 
evidence indicates that Rictor does not directly associate with the actin cytoskeleton (data 
not shown). 
mTORC2 is required for actin polymerization in neutrophils stimulated by fMLP 
As both AKT phosphorylation and mTOR kinase activity were found not to be in 
the regulatory pathway of neutrophil chemotaxis by mTORC2, what might be the 
mechanism used by mTORC2 to regulate neutrophil chemotaxis? Previous reports have 
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suggested a physiological role for TORC2 in regulation of the actin cytoskeleton 
(Wullschleger et al., 2006). TORC2 in budding yeast regulated the cell cycle-dependent 
polarization of actin cytoskeleton (Schmidt et al., 1996). In D. discoideum, TORC2 
controlled actin polarization and cAMP-induced chemotaxis (Kamimura et al., 2008; Lee 
et al., 2005). In HeLa cells and 3T3 fibroblasts, depletion of mTORC2 caused structural 
changes in the actin cytoskeleton, leading to disassembly of stress fibers (Jacinto et al., 
2004; Sarbassov et al., 2004). Both dHL-60 cells and primary neutrophils undergo 
reorganization of the actin cytoskeleton in response to chemoattractants during 
chemotaxis. Inhibition of actin cytoskeletal dynamics by inhibitors impaired neutrophil 
chemotaxis.  
To examine whether the defects of chemotaxis in Rictor- depleted cells is indeed 
due to the inhibition of actin polymerization, we measured the content of filamentous 
actin (F-actin) in cells with or without Rictor depletion (Figure 3.7). Exposure of 
suspended dHL-60 cells induced transient actin polymerization, which could be measured 
by flow cytometry after fixation. In control cells (Non-target shRNA), fMLP treatment 
induced a quick and transient F-actin formation, with a peak at around 1 minute (2.44 ± 
0.14 fold of resting cells, n=3) (Figure 3.7A). Rictor depletion caused the reduction of F-
actin levels even at resting condition (Rictor shRNA-1, 0.74 ± 0.07; Rictor shRNA-2, 
0.75 ±0.12; non-target shRNA) (Figure 3.7A). In addition, treatment with torin 1 or Akti-
1/2 failed to alter F-actin formation (data not shown). When cells were plated on the 
substrate fibrinogen and exposed to uniform concentration of fMLP, control cells 
developed polarized morphology with F-actin concentrated in the leading edge as 
revealed by fluorescence-conjugated phallodin staining (Figure 3.7B, the top panel). 
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Under the same conditions, cells with Rictor depletion failed to develop fully polarized 
morphology (Figure 3.8B, the middle and bottom panel). Along the membrane, we often 
observed small protrusions containing patched F-actin. After exposure to uniform fMLP 
stimulation, about 12% of Rictor-depleted cells polarized with a typical morphology, 
compared to about 70% of control cells (Figure 3.7C). 
 In live cell experiments, we expressed non-target shRNA or rictor shRNA in 
actin-YFP stable expressing cells and assessed the localization of actin-YFP in live cells. 
Control cells polarized and migrated toward the micropipette tip. During the process of 
migration, initially diffuse actin-YFP translocated to the membrane and finally 
concentrated at the leading front of chemotaxing cells (Figure 3.7D). In contrast, actin-
YFP remained diffuse in cells with Rictor depletion through the course of experiment 
(Figure 3.7D). Taken together, mTORC2 disruption by Rictor depletion significantly 
inhibits fMLP-induced actin polymerization in dHL-60 cells.      
Disruption of mTORC2 inhibits Rac activation 
How might mTORC2 regulate actin polymerization during neutrophil 
chemotaxis? Among the Rho GTPases, Rac proteins have been documented as the key 
regulators for actin cytoskeleton in leukocytes and many other cells (Etienne-Manneville 
and Hall, 2002; Sanchez-Madrid and del Pozo, 1999). Rac2 has been identified only in 
hematopoietic cells and is more abundant than Rac1 in neutrophils. Rac2 knockout in 
mice or expression of dominant negative Rac2 mutant in human patients caused the 
dramatic attenuation of actin polymerization in neutrophils (Roberts et al., 1999; 
Williams et al., 2000). In NIH 3T3 cells, mTORC2 depletion inhibited Rac activation 
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induced by serum (Jacinto et al., 2004). To examine whether mTORC2 depletion also 
affects Rac activation induced by chemoattractants, we assessed the level of GTP-bound 
Rac by using GST-PBD pull down assay (Figure 3.8). After fMLP stimulation, we 
observed that the level of Rac-GTP in control cells quickly increased within 30 seconds 
and returned back to the resting level after 5 minutes. In Rictor-depleted cells, the level of 
active Rac was reduced to 37.6% ± 3.7% of control (Figure 3.8A,B). The reduced level of 
Rac-GTP corresponded well to the level of F-actin in Rictor depleted cells. When cells 
were plated on fibrinogen-coated plates, Rac activation was already observed in control 
cells even without chemoattractant stimulation, which is consistent with a previous report 
that integrin ligation can induce Rac activation (Price et al., 1998). After fMLP 
stimulation, the level of Rac-GTP increased about 10~20 % in 1 minute and returned to 
the level of unstimulated condition after 5 minutes. Rictor depletion also reduced Rac 
activation under adherent conditions (Figure 3.8C, D). 
Recently, Liu and colleagues reported that mTORC2 negatively regulated RhoA 
through activation of adenylyl cyclase 9 (AC9) (Liu et al., 2010). Rictor depletion caused 
the inhibition of cAMP production and resulted in elevated RhoA activation. In 
suspended cells, we also observed elevated content of RhoA-GTP in 1 minute after fMLP 
stimulation (Figure 3.9A). However, under adherent conditions, no significant difference 
of RhoA activation was observed between control and Rictor-depleted cells (Figure 
3.9B). Myosin phosphorylation (MLRC p-S19) has been shown as the downstream event 
of activated RhoA. In Rictor-depleted cells, we observed increased staining of myosin 
phosphorylation in the back region of the cell body, compared to that of control. 
Incubation with Y27632, an inhibitor for ROCK, completely abolished phosphorylated 
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Myosin light chain staining in cells (Figure 3.9C). In conclusion, although Rictor 
depletion affected the backness pathways, the failure of polarization in Rictor-depleted 
cells strongly indicates that the chemotactic defect was mainly due to inhibition of actin 
polymerization.    
3.5 Discussion 
Previous studies have established the key roles of TOR signaling in cell growth 
(Wullschleger et al., 2006). At least two TOR signaling branches have been identified. 
The TORC1 signaling branch, which is sensitive to rapamycin, regulates the temporal 
aspect of cell growth and has been intensively studied over the past decades. In contrast, 
the TORC2 signaling branch, insensitive to rapamycin, is not well understood. A line of 
evidence indicates that TORC2 regulates actin cytoskeleton in budding yeast and 
mammalian cell lines. Recently, TORC2 has been documented as an important regulator 
of D. discoideum chemotaxis in response to cAMP (Cai et al., 2010; Lee et al., 2005; Liu 
et al., 2010). In this study, we found that mTORC2 was required for fMLP-induced 
neutrophil chemotaxis. Based on our findings, a model has been proposed to explain the 
function of mTORC2 in neutrophil chemotaxis. As described in Figure 3.10, mTORC2 
acts downstream of activated Gi protein and regulates actin polymerization and 
neutrophil chemotaxis through controlling Rac activation. This mTORC2-mediated 
regulation is independent of AKT activation and mTOR kinase activity.  First, inhibiton 
of AKT and mTOR kinase activity failed to recapitulate the defect of chemotaxis 
observed in mTORC2-depleted cells. Second, mTORC2 depletion profoundly impairs 
chemoattractant-induced actin polymerization and neutrophil polarity. Third, we found 
mTORC2 depletion inhibited the activation of Rac proteins, essential regulators of actin 
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cytoskeleton in neutrophils. Our findings further confirm and expand the role of 
mTORC2 in organization of actin cytoskeleton in neutrophils. 
How might mTORC2 regulate actin cytoskeleton during chemotaxis? In D. 
discoideum, TORC2 depletion reduced cell polarity and migration speed. This defect 
seemed dependent on the inhibition of PKB/PKBR phosphorylation due to TORC2 
knockout (Kamimura et al., 2008; Lee et al., 2005). Furthermore, Ras has been shown to 
function upstream to control TORC2 activation and downstream events (Cai et al., 2010). 
Interestingly, TORC2 deletion in D. discoideum only modestly affected filamentous actin 
formation and the structure of the actin cytoskeleton. TORC2 depletion strongly impairs 
the activation of adenylyl cyclase which is required for cAMP production. Our findings 
differ from the above reports. Depletion of mTORC2 dramatically impaired chemotaxis 
of dHL-60 cells. After stimulation by fMLP, most cells could not persistently protrude 
and failed to form stable polarity in the absence of mTORC2. The downstream effector 
AKT is probably not the mediator of mTORC2 in neutrophil chemotaxis, as we showed 
that the inhibition of AKT failed to affect neutrophil chemotaxis (Figure 3.4). 
Furthermore, inhibition of mTOR kinase activity did not affect neutrophil chemotaxis 
either, further suggesting that kinase activity-indepenent function of mTORC2 regulates 
actin cytoskeleton and neutrophil chemotaxis (Figure 3.5). Evidence suggests that kinase-
independent functions exist in TORC to control myogenesis (Erbay and Chen, 2001; Ge 
et al., 2009). Taken together, mammalian cells like neutrophils might have acquired new 
functions of mTORCs to modulate actin cytoskeleton and cell motility, which are 
independent on mTOR kinase activities and the mTORC downstream effector AKT. 
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Very recently, Liu et al reported that mTORC2 controlled neutrophil chemotaxis 
through cAMP and in a RhoA-dependent fashion (Liu et al., 2010). In their study, cells 
with Rictor depletion failed to polarize, but had comparable filamentous actin formation 
to control cells in reponse to chemoattractant. This is in contrast to our finding that 
mTORC2 depletion dramatically impaired actin cytoskeleton even without 
chemoattractants. It is worth noting that in HeLa cells and 3T3 fibroblasts, mTORC2 
depletion affected actin polymerization and dramatically altered the structure of actin 
cytoskeleton characterized by the disappearance of stress fibers. Our findings support a 
conserved role of mTORC2 in the regulation of actin cytoskeleton among mammalian 
cells. Furthermore, the phenotypic defect of Rictor depletion was very different from the 
adenylyl cyclase 9-depleted cells which developed long tails in response to 
chemoattractants. Based on our findings, a major role of mTORC2 is in the regulation of 
actin polymerization and thus is involved in leading edge formation. It is possible that the 
defect in the leading edge of mTORC2-depleted cells might affect the contractility 
machinery in the back, as indicated by the increase of RhoA and myosin II activation 
(Figure 3.10). These discrepancies may be due to the differences in cell lines used in 
these experiments.  Further studies are needed to clarify these discrepancies of mTORC2 
function in neutrophil chemotaxis. 
Similar to NIH 3T3 cells, Rac proteins have been identified as the downstream 
regulator of mTORC2 in neutrophil chemotaxis. Studies with knockout mouse and 
human primary neutrophils with dominant negative Rac mutant indicate that Rac proteins 
are the major regulators of actin cytoskeleton. In mTORC2 depleted cells, reduced Rac 
activation was observed after fMLP stimulation. How mTORC2 regulates Rac activation 
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is an interesting question for future studies. In neutrophils, DOCK2 and p-Rex have been 
identified as two nucleotide exchange factors for Rac activation. It is intriguing to 
determine whether one or both GEFs are regulated by mTORC2. However, the severity 
of chemotaxis in mTORC2-depleted cells suggests that there may be other additional 
mechanisms used by mTORC2 to regulate actin cytoskeleton.        
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Figure 3.1 Expression and depletion of mTOR, Rictor and Raptor. (A) mTOR, Rictor and 
Raptor are expressed in neutrophil-like cell line HL-60 cells and human primary 
neutrophils. Human neutrophils, undifferentiated HL-60 cells (uHL-60) and differentiated 
HL-60 cells (dHL-60) were lysed in RIPA buffer and analyzed by western blotting. 
GAPDH is the loading control. (B) mTORC depletion in dHL-60 cells. HL-60 cells were 
infected with lenti-viral particles containing respective shRNAs overnight and then 
induced to differentiate for 5 days. Cell lysates were analyzed by western blotting. 
GAPDH is the loading control. (B) The knockdown efficiency of mTOR, Raptor or Rictor
by respective shRNAs. The Y axis represents the densitometry of remaining protein after 
knockdown. Values are means  SEM (n = 3)
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Figure 3.2 (cont.) mTORC2 depletion impairs dHL-60 chemotaxis. (A) Chemotaxis of control 
dHL-60 cells (NT shRNA) or dHL-60 cells with depletion of mTOR, Rictor or Raptor in microfluidic 
chamber. Cells (2  106) were loaded to fibrinogen – coated microfluid device chamber for 20 
minutes and exposed to an fMLP gradient (20 minutes) generated by the microfluidic device. As 
shown are the images for cells at two time points in each condition. Bar, 50 µm. (B) The enlarged 
view of cells after the stimulation of the fMLP gradient. Bar, 10 µm. (C) The outlines of cells 
responding to the fMLP stimulation in microfluidic chamber. Each set of outlines represents a 
single cell observed at indicated intervals (denoted by different colors) after exposure to fMLP. 
Two representative cells were shown for each condition. (D) Quantification of chemotactic dHL-60 
cells with or without mTORC depletion in microfluid device. During the experiments, cells within 
the 200 µm region of the lowest fMLP concentration (bottom) were examined and the percentage 
of cell migration is calculated as the ratio of chemotactic cells vs total cells. Values are means  
SEM (n = 3). (E) Cell migration in response to the point source of fMLP. Cells treated with non-
target shRNA, mTOR shRNA-3, Rictor shRNA-1 or Raptor shRNA-1 were plated on fibrinogen 
coated slides for 20 minutes and then stimulated by fMLP delivered from a micropipette. The two 
time lapse images for each condition were shown. The bar represents 10 µm.
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Figure 3.3 Rictor depletion did not affect HL-60 survival and differentiation. (A) 
Apoptotic assay of control cells or mTORC2 depleted cells. Cells were 
infected with lenti-viral particles containg non-target shRNA, mTOR shRNA-3 
or Rictor shRNA-1 and differentiated for 5 days. Cells were prepared 
according to the manual (FITC Annexin V Apoptosis Detection Kit I, BD 
Pharmingen) and analyzed by flow cytometry. (C)  Flow cytometry analysis of 
surface expression of β2 integrin in control and mTORC2 depleted cells after 
fMLP stimulation (100 nM, 10 min). The black line indicates background 
fluorescence from the isotype control IgG. 
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Figure 3.4 (cont.) The downstream effector AKT is not involved in mTORC2 
mediated regulation of neutrophil chemotaxis. (A) Phosphorylation of AKT (p-S473) 
in response to fMLP stimulation (100 nM) for various time points. (B) The average 
level of AKT phosphorylation (p-S473) at various time points after fMLP stimulation. 
Values are means  SEM (n = 3). (C) Rictor depletion inhibits AKT phosphorylation 
(p-S473) induced by fMLP. Total AKT is the loading control, and Rictor blot is also 
shown. (D) Quantification of AKT phosphorylation (p-S473) in dHL-60 cells with or 
without Rictor depletion at the time point of 1 minute. Values are means  SEM (n = 
3). (E) AKTi 1/2 inhibits fMLP induced AKT phosphorylation. Cells were treated with 
various concentrations of AKTi 1/2 for 30 minutes and stimulated with 100 nM fMLP
for 1 minute. The level of AKT phosphorylation, p-S473 or p-T308, were assessed by 
western blotting. (F) The chemotaxis of dHL-60 cells treated with AKTi 1/2 (1µM) in 
micorfluid device. Bar, 50 µm.
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Figure 3.5 (cont.)
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Figure 3.5 (cont.) mTORC inhibition by rapamycin or torin 1 failed to affect 
neutrophil chemotaxis. (A) mTORC inhibition by rapamycin or torin 1. dHL-60 cells 
were pretreated with vehicle (DMSO), rapamycin (100 nM) or torin1 (250 nM) for 30 
minutes and stimulated with fMLP (100 nM) for indicated time points. 
Phosphorylation of AKT (p-S473) and S6K1 (p-T389) was analyzed by western 
blotting. AKT is the loading control. (B) Quantification of AKT phosphorylation (p-
S473) in dHL-60 cells with or without mTORC inhibition. The values are normalized 
to the peak level of AKT phosphorylation (1 minute). Values are means  SEM (n = 
3). (C) Quantification of S6K1 phosphorylation (p-T389) in in dHL-60 cells with or 
without mTORC inhibition. The values are normalized to the peak level of S6K1 
phosphorylation (5 minutes). Values are means  SEM (n = 3).  (D) chemotaxis of 
dHL-60 treated with vehicle, rapamycin (100 nM) or torin 1(250 nM). Cells were pre-
treated with above reagents for 30 minutes and then loaded to the fibrinogen-coated 
microfluidic device. The chemotactic cells in each condition were monitored by time-
lapse microscopy. As shown are the images for cells at two time points in each 
condition. Bar, 50 µm. (E) trajectory of dHL-60 cells. dHL-60 cells were pretreated 
with vehicle (DMSO), rapamycin (100 nM) or torin 1(250 nM) for 30 minutes and 
then plated on fibrinogen coated microfluid device chamber. Cell migration was 
recorded by time lapse microscope. The migration path of individual cells was 
analyzed by Image J and plotted.
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Cells Parameters DMSO (veh.) Rapamycin Torin 1
dHL-60 Speed
(μm/min)
4.36± 0.16 4.39± 0.12 4.67± 0.13
Chemotaxis
index
0.97± 0.01 0.95± 0.01 0.96± 0.01
PMN Speed
(μm/min)
7.05± 0.12 7.40± 0.55 7.47± 0.21
Chemotaxis
index
0.96± 0.01 0.97± 0.01 0.96± 0.01
Table 1 Effects of drug inhibition on dHL-60 and PMN chemotaxis
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Figure 3.6 (cont.) mTORC2 accumulates in the leading edge of chemotactic 
dHL-60 cells. (A) Immunofluorescence of Rictor (red) and F-actin (green) in
cells plated on fibrinogen without or with fMLP stimulation (100 nM, 2 minutes). 
Fluorescent images of Rictor (red),  F-actin (green), Rictor/F-actin merged 
images and DIC images of cells are shown. Also shown is the staining of Rictor
and F-actin in the presence of anti-Rictor blocking peptide for fMLP treated 
cells.  Bar, 10 µm. (B) The fluorescence line profile of Rictor (Red) and F-actin 
(Green) in stained dHL-60 cells. The fluorescence intensity cross the center of 
cell body (unstimulated cell) or from the front to back of cell body (stimulated 
cell) was measured with Image J and plotted. (C) The relative fluorescence 
intensity of Rictor and F-actin in the leading edge of fMLP-stimulated dHL-60 
cells. The first 4 µm from the edge of front is designated as “front” and the left 
of cell body is defined as “back”. The ratio of fluorescence intensity for both F-
actin and Rictor (front vs back) was measured by Image J. As shown is the 
result from 41 stained cells from at least 3 independent experiments. 
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Figure 3.7 (cont.) mTORC2 depletion impairs actin polymerization in chemotactic dHL-60 
cells. (A) The content of F-actin in dHL-60 cells. dHL-60 cells with or without Rictor depletion 
were stimulated with fMLP (100 nM) for indicated time points. Cells were immediately fixed, 
permeablized and stained by fluorescence conjugated phalloidin. The binding of phalloidin to 
the cells was analyzed by flow cytometry. As shown are the values from four independent 
experiments. Means  s.e.m. (B) F-actin staining in fMLP stimulated dHL-60 cells with or 
without Rictor depletion. Cells were plated on fibrinogen-coated slide for 20 minutes and 
stimulated with uniform fMLP (100 nM) for 2 minutes. Cells were immediately fixed, 
permeablized and stained by fluorescence conjugated phalloidin. The images of F-actin and 
DIC are shown. Bar,10 µm. (C) Quantification of palorized cells in response to uniform fMLP
(100 nM). Cells were treated as described in (B). Cells were examined from at least three 
independent experiments: non-targeted shRNA (252 cells), Rictor shRNA-1 (255 cells) and 
Rictor shRNA-2 (304 cells). (D) Actin-YFP dynamics in live dHL-60 cells. Actin-YFP stable 
expressing cells were treated with non-target shRNA or Rictor shRNA-1 and differentiated for 
5 days. Cells were plated on fibrinogen-coated slides and stimulated by a point source of 
fMLP delivered by micropipette. The four images in each row show the positions of individual 
cells after exposure to fMLP. all bars represent 10 µm. 
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Figure 3.8  mTORC2 depletion inhibits fMLP induced Rac activation. (A)  Rac-GTP 
pulldown in dHL-60 cells with or without Rictor depletion under suspension condition. 
cells were stimulated with 100 nM of fMLP for indicated time points and lysed for the pull-
down assay. Levels of total Rap1 was used to show equal cell lysate input. (B) 
Quantification of relative levels of Rac-GTP level in dHL-60 cells with and without Rictor
depletion 30 seconds after fMP stimulation. Each bar represents the mean SEM (error 
bars). Values are normalized to the level of Rac-GTP (=1) in cells without Rictor
depletion. Asterisks indicate that the value for cells with Rictor depletion differs 
statistically from the control (*, p<0.001, n=3). (C) The levels of Rac-GTP in adherent 
dHL-60 cells under various conditions. Control cells or Rictor-depleted cells plated on 
fibrinogen-coated plates were unstimulated or stimulated for 1 or 5 minutes with a 
uniform concentration of fMLP (100 nM) and lysed for pull-down assay. Levels of total 
Rac was used to show cell lysate input. (D) Quantification of relative levels of Rac-GTP 
level in experiments described in (C). Values are normalized to the level of Rac-GTP (=1) 
in cells without Rictor depletion stimulated with fMLP. Each bar represents the 
mean SEM (error bars) (n=3).
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Figure 3.9 mTORC2 depletion enhance fMLP induced RhoA activation and myosin 
phosphorylation. (A) Quantification of RhoA-GTP in dHL-60 cells with or with Rictor
depletion under suspension condition. Cells were stimulated with fMLP (100 nM) for 
times indicated and lysed. The level of RhoA-GTP was determined by the use of an 
absorbance-based RhoA G-LISA kit. The y axis represents the absorbance at 490 
nm. Each bar represents the mean  s.e.m. (error bars) (n=4) (B) Quantification of 
RhoA-GTP dHL-60 cells with or with Rictor depletion under adherent condition.  Cells 
were suspended in mHBSS buffer and plated on fibrinogen-coated plates for 30 
minutes. Cells were then stimulated by 100 nM fMLP for indicated times and lysed. 
The level of RhoA-GTP was determined by the use of an absorbance-based RhoA G-
LISA kit. The y axis represents the absorbance at 490 nm. Each bar represents the 
mean  s.e.m. (error bars) (n=3). (C) Merged fluorescent images of p-MLC (red) and 
F-actin (green) in control, Rictor-depleted cells and cells pretreated with Y-27632 (30 
μM, 30 min). The corresponding DIC images are shown. The white arrow indicates 
the loss of p-MLC fluorescence at the back of the Y-27632-treated cell. Bars, 10 μm.
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Figure 3.10 The current model of mTORC2 in neutrophil chemotaxis. mTORC2 is 
activated by Gi protein and controls Rac activation and actin polymerization through 
the fashion of  AKT phosphorylation –independent and kinase activity-independent 
pathways. Concomitantly,  mTORC2 down-regulates RhoA activation, as shown 
increased myosin phosphorylation. 
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CHAPTER 4 CONCLUSION 
This dissertation is the summary of my research work conducted in Dr. Fei 
Wang’s laboratory during my graduate studies at the University of Illinois at Urbana-
Champaign. My major research goal was to dissect the molecular mechanism of signal 
transduction during neutrophil chemotaxis. As described in previous chapters, neutrophil 
chemotaxis, as well as other types of cell migration, is a complex process regulated by 
the integration of multiple signaling pathways. I have worked on two research projects: 
the signaling mechanisms regulating interaction between chemotactic neutrophils and 
substrate, and the mechanisms of actin cytoskeleton dynamics. By using the genetically 
tractable cell line (dHL-60), we have documented a novel signaling pathway by which 
non-receptor tyrosine kinase Lyn controls leading edge adhesion. We have also found 
that mTORC2 is an essential regulator of actin polymerization during neutrophil 
chemotaxis. 
In Chapter 2, I have described the function of Lyn kinase in neutrophil 
chemotaxis. Although Lyn kinase has been shown to be activated by many cell surface 
receptors, the molecular details of Lyn kinase function in neutrophil chemotaxis has not 
been fully explored. The data presented in this chapter show that Lyn kinase was 
activated and translocated to the leading edge upon fMLP stimulation. Using the 
approach of RNA interference, we demonstrated that Lyn kinase was required for the 
persistent migration of dHL-60 cells in the migration settings of micropipette and 
microfluid device. Lyn depletion did not affect the signaling pathways regulating PI3K, 
Rac activation and actin polymerization. Although Lyn-depleted cells had a similar 
phenotype to cells with defects in the backness pathways, Lyn depletion did not affect 
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RhoA activation and myosin phosphorylation. Furthermore, we observed that Lyn 
depletion reduced the accumulation of active β2 integrin in the leading edge without 
altering the total β2 distribution. Interestingly, blocking de novo adhesion by β2 antibody 
recapitulated the defects observed in Lyn-depleted cells. At the molecular level, Lyn 
depletion inhibited fMLP-induced Rap1 activation, a known upstream event of β2 
integrin activation pathways. In Lyn-depleted cells, the level of active Rap1 was reduced 
in the leading edge of live chemotactic cells when compared to that of control cells. We 
further found that the reduced activation of Rap1 in Lyn-depleted cells corresponded to 
the inhibition of CrKL/C3G recruitment to the leading edge. In summary, our data in 
Chapter 2 have revealed a novel signaling pathway by which Lyn kinase regulates 
leading edge adhesion during neutrophil chemotaxis. However, there are some 
unanswered questions about how Lyn kinase regulates CrKL/C3G recruitment and, thus, 
integrin activation. 
In Chapter 3, I have presented the results on the role of mTORC2 on neutrophil 
chemotaxis. Dynamics of the actin cytoskeleton are thought to be essential for neutrophil 
chemotaxis as well as other types of cell migration. We report in this chapter that 
mTORC2 disruption severely inhibited dHL-60 cell chemotaxis when cells were exposed 
to a point source of fMLP by micropipette or a linear fMLP gradient by microfluid 
device. This migratory defect was not due to inhibition of mTORC2 kinase activity, as 
shown that inhibition of AKT and mTOR kinase did not affect chemotaxis of dHL-60 
cells and neutrophils. mTORC2 depletion strongly inhibited actin polymerization induced 
by fMLP in dHL-60 cells. When mTORC2-depleted cells were plated on fibrinogen 
substrate, they failed to form the typical polarized morphology as seen in control cells. At 
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the molecular level, mTORC2 depletion inhibited Rac activation by fMLP stimulation. 
How mTORC2 regulates Rac activation and actin polymerization are under investigation. 
The answer to these questions would also shed light on the regulatory mechanism of 
mTORC2 on actin cytoskeleton in other types of cells.  
   As mentioned previously, we have begun to unravel the complex signaling 
mechanism underpinning neutrophil chemotaxis by using the transgenic mouse and 
neutrophil-like cell lines.  However, there are many remaining questions regarding how 
neutrophils respond to attractants at the molecular and cellular levels, especially the 
signaling cascades involved in the regulation of cell adhesion. In the future, more insights 
on the integrated signaling pathways which temporally and spatially regulate neutrophil 
chemotaxis will be obtained through the development of new methodologies and 
technologies, such as the application of intravital microsopy to observe chemotaxing 
neutrophils in the animal body. 
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